var title_f39_58_40864="Indeterminate leprosy";
var content_f39_58_40864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Indeterminate leprosy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 357px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Indeterminate disease with the typical hypopigmented to slightly erythematous macule (white arrow),which has diminished sensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from McDougall AC, Yuasa Y. A New Atlas of leprosy, Sasakawa Memorial Health Foundation, Tokyo, 2000, and Guinto RS, Abalos RM, Cellopna RV, Fajardo TT. An Atlas of Leprosy, Sasakawa Memorial Health Foundation, Tokyo, 1983.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40864=[""].join("\n");
var outline_f39_58_40864=null;
var title_f39_58_40865="Carotid-cavernous fistula";
var content_f39_58_40865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F78809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F78809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI of a carotid-cavernous fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal postcontrast fat-suppressed T1-weighted image shows enlargement of the extraocular muscles in both orbits. Note the prominent right superior ophthalmic vein (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eisenberg RL. An Atlas of Differential Diagnosis, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40865=[""].join("\n");
var outline_f39_58_40865=null;
var title_f39_58_40866="Livedo reticularis";
var content_f39_58_40866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Livedo reticularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 353px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with lupus and anti-phospholipid antibodies with livedo reticularis (manifested by a reddish-cyanotic, reticular pattern of the skin) which has resulted in ulcer formation (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Samuel Moschella, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40866=[""].join("\n");
var outline_f39_58_40866=null;
var title_f39_58_40867="Preeclampsia";
var content_f39_58_40867=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Preeclampsia (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/58/40867/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40867/contributors\" id=\"au4555\">",
"       Vanessa A Barss, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40867/contributors\" id=\"au4987\">",
"       John T Repke, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/58/40867/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40867/contributors\" id=\"se4723\">",
"       Charles J Lockwood, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/58/40867/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40867/contributors\" id=\"de1930\">",
"       Sandy J Falk, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/58/40867?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     There are four major types of high blood pressure that may occur during pregnancy:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Preeclampsia",
"      </li>",
"      <li>",
"       Chronic hypertension",
"      </li>",
"      <li>",
"       Preeclampsia superimposed upon chronic hypertension",
"      </li>",
"      <li>",
"       Gestational hypertension (also called transient hypertension)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     This topic will review high blood pressure related to preeclampsia, the treatment of preeclampsia, and the possible complications of preeclampsia.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS PREECLAMPSIA?",
"     </span>",
"    </p>",
"    <p>",
"     Women with preeclampsia gradually develop high blood pressure (hypertension) and excess protein in the urine (proteinuria). Signs of preeclampsia can appear anytime during the last half of pregnancy (after 20 weeks of pregnancy) or in the first few days postpartum, and typically resolve within a few days after delivery.",
"    </p>",
"    <p>",
"     Preeclampsia is sometimes called by other names, including toxemia, pregnancy-induced hypertension, and preeclamptic toxemia. It is mild in most cases. One severe form of preeclampsia is called HELLP syndrome (H = hemolysis, EL = elevated liver enzymes, LP = low platelets). A woman is said to have eclampsia if she has one or more seizures and has no other conditions that could have caused the seizure.",
"    </p>",
"    <p>",
"     In the United States, preeclampsia occurs in 5 to 8 percent of pregnancies. Most cases occur at or near term (after 37 weeks of pregnancy), although 10 percent of cases occur before 34 weeks of pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Chronic hypertension",
"     </span>",
"     &nbsp;&mdash;&nbsp;Chronic hypertension is defined as a blood pressure",
"     <span class=\"nowrap\">",
"      &ge;140/90",
"     </span>",
"     mmHg diagnosed before pregnancy, before the 20th week of pregnancy, or that persists more than 12 weeks after delivery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Chronic hypertension with superimposed preeclampsia",
"     </span>",
"     &nbsp;&mdash;&nbsp;This refers to a woman with chronic hypertension who develops signs of preeclampsia after the 20th week of pregnancy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Gestational hypertension",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women with gestational hypertension have all of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Blood pressure",
"       <span class=\"nowrap\">",
"        &ge;140/90",
"       </span>",
"       mmHg",
"      </li>",
"      <li>",
"       No protein in the urine (proteinuria)",
"      </li>",
"      <li>",
"       Are &ge;20 weeks pregnant",
"      </li>",
"      <li>",
"       No previous history of high blood pressure.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Over time, some pregnant women with gestational hypertension will develop proteinuria and be considered preeclamptic, while others will be diagnosed with chronic hypertension because of persistently high blood pressure after delivery.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      WOMEN AT RISK FOR PREECLAMPSIA",
"     </span>",
"    </p>",
"    <p>",
"     Women with preeclampsia have smaller than normal blood vessels feeding the placenta, although the exact cause of this abnormality is not known. There are no tests that can reliably predict who will get preeclampsia, and there is no way to prevent it. Women with one or more of the following characteristics have an increased risk of developing preeclampsia:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       First pregnancy (excluding miscarriages)",
"      </li>",
"      <li>",
"       High blood pressure, kidney disease, lupus, or diabetes prior to pregnancy",
"      </li>",
"      <li>",
"       Gestational diabetes",
"      </li>",
"      <li>",
"       Multiple gestation (eg, twins or triplets)",
"      </li>",
"      <li>",
"       A family history of preeclampsia in a sister or mother",
"      </li>",
"      <li>",
"       A previous history of preeclampsia",
"      </li>",
"      <li>",
"       Age under 20 years and possibly age over 35 to 40 years",
"      </li>",
"      <li>",
"       Obesity",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Conversely, women who do not develop preeclampsia in their first pregnancy are at low risk of developing it in a subsequent pregnancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      PREECLAMPSIA SIGNS AND SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     The signs and symptoms of preeclampsia occur, in part, due to changes inside the small arteries, which decreases blood flow to major maternal organs such as the kidney, brain, and liver, as well as the placenta.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Maternal",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most women with preeclampsia never experience anything more than mild high blood pressure and a small amount of excess protein in the urine. These changes do not cause symptoms; therefore, prenatal visits to check blood pressure and measure urinary protein are scheduled frequently in the last half of pregnancy.",
"    </p>",
"    <p>",
"     Swelling (edema) was once considered to be a sign of preeclampsia, especially when it occurred in the face or hands. However, since many women who do not have preeclampsia also develop swelling, it is no longer considered a reliable sign of the disease.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Signs of severe preeclampsia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mild preeclampsia can worsen and become severe. This usually occurs over several days to weeks, but may occur more quickly. Severe preeclampsia may be characterized by one or more of the following signs or symptoms. However, the signs of both mild and severe preeclampsia may be subtle, and patients should not hesitate to mention any concerns about possible signs of preeclampsia to their provider:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Blood pressure",
"       <span class=\"nowrap\">",
"        &ge;160/110",
"       </span>",
"       mmHg. Women with blood pressures in this range have an increased risk of stroke",
"      </li>",
"      <li>",
"       Persistent severe headache",
"      </li>",
"      <li>",
"       Visual problems (blurred or double vision, blind spots, flashes of light or squiggly lines, loss of vision)",
"      </li>",
"      <li>",
"       Abnormal kidney tests or decreased urination (urinating less than 500 mL in 24 hours)",
"      </li>",
"      <li>",
"       Fluid in the lungs, which may cause new shortness of breath",
"      </li>",
"      <li>",
"       Low platelet count; platelets help the blood to clot, which may cause easy bruising or bleeding",
"      </li>",
"      <li>",
"       Liver abnormalities (detected by blood tests); symptoms may include nausea, vomiting, or pain in the mid- or right upper abdomen (similar to heartburn)",
"      </li>",
"      <li>",
"       Destruction of red blood cells (hemolysis, which is detected by blood tests).",
"      </li>",
"      <li>",
"       Partial or complete separation of the placenta from the uterus (called abruption); symptoms include vaginal bleeding, uterine pain,",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       decreased fetal activity",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Fetal",
"     </span>",
"     &nbsp;&mdash;&nbsp;Blood flow to the placenta carries oxygen and nutrients from mother to baby. Preeclampsia can reduce blood flow to the placenta, which can the following effects on the baby:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Abnormal nonstress test or biophysical profile score (see",
"       <a class=\"local\" href=\"#H16\">",
"        'Fetal monitoring'",
"       </a>",
"       below)",
"      </li>",
"      <li>",
"       Slowed growth of the baby, based upon an ultrasound",
"      </li>",
"      <li>",
"       Decreased amount of amniotic fluid around the baby, noted on ultrasound",
"      </li>",
"      <li>",
"       Decreased blood flow through the umbilical cord, noted on Doppler tests (performed during ultrasound).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      PREECLAMPSIA MANAGEMENT",
"     </span>",
"    </p>",
"    <p>",
"     The only cure for preeclampsia is delivery of the baby and placenta. Although bedrest and taking high blood pressure medication can lower blood pressure and reduce the risk of stroke, these treatments do not improve the abnormalities in the mother's blood vessels.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      At term",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most effective treatment for preeclampsia at or near term (after 37 weeks of pregnancy) is to deliver the baby. This helps to minimize the risk of harm to the woman or her baby from worsening preeclampsia. Babies at or near term are not at high risk of complications from prematurity and usually will not need to spend time in a special care nursery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Before term",
"     </span>",
"     &nbsp;&mdash;&nbsp;If mild preeclampsia occurs before term, it may be possible to delay delivery to allow the baby more time to grow and mature, while monitoring the woman and baby closely. If severe preeclampsia occurs before term, delivery is often necessary to prevent complications in the woman or her baby.",
"    </p>",
"    <p>",
"     The method of delivery (vaginal or cesarean birth) depends upon a number of factor, such as the position of the baby, the dilatation and effacement (thinning) of the cervix, and the baby's condition. In most situations, vaginal delivery is possible.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Steroids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Babies delivered prematurely are at risk for breathing problems because their lungs may not be fully developed. Women who are likely to require preterm delivery (at or before 34 weeks of pregnancy) are usually given two steroid injections (eg, betamethasone) to speed fetal lung development. The steroids also decrease other potential complications of preterm birth, such as intraventricular hemorrhage (bleeding into the brain). The two injections must be given 24 hours apart, and the full benefit of the treatment occurs 48 hours after the first injection.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Maternal monitoring",
"     </span>",
"     &nbsp;&mdash;&nbsp;When delivery is delayed, the mother and baby will be monitored. The woman may be admitted to the hospital or may be allowed to stay at home and have frequent office visits. Women who are at home should call their healthcare provider immediately if any of the signs or symptoms of severe preeclampsia develop (see",
"     <a class=\"local\" href=\"#H8\">",
"      'Maternal'",
"     </a>",
"     above).",
"    </p>",
"    <p>",
"     Maternal monitoring usually includes blood pressure measurements and blood and urine tests to check liver and kidney function, and blood cell counts.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Fetal monitoring",
"     </span>",
"     &nbsp;&mdash;&nbsp;Fetal monitoring includes a combination of nonstress tests and ultrasound examination.",
"    </p>",
"    <p>",
"     Non-stress testing is performed to monitor the baby's condition. It is done by measuring the baby's heart rate with a small device that is placed on the mother's abdomen. The device uses sound waves (ultrasound) to measure the baby's heart rate over time, usually for 15 to 30 minutes. Normally, the baby's baseline heart rate should be between 120 and 160 beats per minute. Normally, an increased rate should occur periodically; the increase should be at least 15 beats per minute above the baseline heart rate for 15 seconds. The test is considered reassuring if two or more fetal heart rate increases are seen within a 20 minute period. Further testing may be needed if these increases are not observed after monitoring for 40 minutes.",
"    </p>",
"    <p>",
"     Ultrasound is used to monitor the baby's growth, assess its well-being, and evaluate blood flow through the umbilical cord (called a Doppler test). A biophysical profile assesses well-being by using ultrasound to evaluate the baby's movements, breathing activity, movement of the arms and legs, and amniotic fluid volume.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Induced labor",
"     </span>",
"     &nbsp;&mdash;&nbsp;If the mother or baby's test results are concerning, the healthcare provider will usually recommend delivery. The most common reasons for delivery in women with preeclampsia are listed the table (",
"     <a class=\"graphic graphic_table graphicRef53763 \" href=\"mobipreview.htm?11/24/11659\">",
"      table 1",
"     </a>",
"     ):",
"    </p>",
"    <p>",
"     If the cervix is still closed and long, medications may be applied directly to the cervix to help it open and thin. Most women will also require an intravenous medication, oxytocin (Pitocin), to stimulate the uterus to contract. If labor does not progress with these measures, or if complications develop that require the baby to be delivered quickly, a cesarean birth is usually performed. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/45/11988?source=see_link\">",
"      \"Patient information: C-section (cesarean delivery) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Preventing seizures",
"     </span>",
"     &nbsp;&mdash;&nbsp;Because women with preeclampsia can develop eclampsia (seizures), most patients are treated with an anticonvulsant medication. Intravenous (IV) magnesium sulfate is the drug most commonly used to prevent seizures. Dietary supplements that contain magnesium are not effective or recommended for prevention of seizures. IV magnesium is safe, although high blood levels of magnesium can be harmful. The mother and baby are monitored closely during treatment. Magnesium is given to the woman during labor and usually for 24 hours after delivery.",
"    </p>",
"    <p>",
"     Severe hypertension is treated with one or more IV high blood pressure medications to lower the risk of a maternal stroke.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      CARE AFTER DELIVERY",
"     </span>",
"    </p>",
"    <p>",
"     High blood pressure and protein in the urine resolve after delivery, usually within a few days. Severe hypertension should be treated, and some women will require a high blood pressure medication after being discharged from the hospital. This can be discontinued when the blood pressure returns to normal levels, usually within six weeks.",
"    </p>",
"    <p>",
"     Blood pressure that continues to be elevated beyond 12 weeks after delivery is unlikely to be related to preeclampsia and may require long-term treatment. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=see_link\">",
"      \"Patient information: High blood pressure treatment in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      OUTCOMES",
"     </span>",
"    </p>",
"    <p>",
"     Mildly elevated blood pressure over a few weeks or months is not usually harmful; it does not have the same long-term risks (stroke, heart attack) as chronic high blood pressure. Losing protein in the urine due to preeclampsia does not damage the kidneys. In women with mild preeclampsia near term, newborn outcomes are generally good.",
"    </p>",
"    <p>",
"     Severe preeclampsia can cause temporary abnormalities in the woman's liver and kidney function and a low platelet count (thrombocytopenia, which can be associated with bleeding). In women with severe preeclampsia, especially when it occurs preterm, there is an increased risk of preterm delivery and problems related to prematurity, such as low birth weight. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31992?source=see_link\">",
"      \"Short-term complications of the premature infant\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Women who have severe preeclampsia that develops before term, recurrent preeclampsia, or gestational hypertension appear to be at increased risk of cardiovascular disease later in life, including during the premenopausal period.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h1\">",
"      RISK OF PREECLAMPSIA IN FUTURE PREGNANCIES",
"     </span>",
"    </p>",
"    <p>",
"     Most women who experience preeclampsia will not have it in a subsequent pregnancy. The risk of recurrent preeclampsia is between 5 and 70 percent",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Women who developed severe preeclampsia and were delivered before 30 weeks gestation having the highest risk of preeclampsia in future pregnancies.",
"      </li>",
"      <li>",
"       Women with mild preeclampsia near term have only a 5 percent chance of developing it again.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Women with preeclampsia develop high blood pressure (greater than",
"       <span class=\"nowrap\">",
"        140/90",
"       </span>",
"       mmHg) and have protein in their urine. This can occur anytime during the last half of pregnancy (after 20 weeks of gestation) or in the first few days after delivery.",
"      </li>",
"      <li>",
"       Preeclampsia occurs in 5 to 8 percent of pregnancies in the United States. It is not known why some women develop preeclampsia while others do not. Currently, there are no tests that can reliably predict who will get the disease, and there is no way to prevent it.",
"      </li>",
"      <li>",
"       The majority of women with mild preeclampsia have no symptoms. Mild preeclampsia can worsen and become severe. Severe preeclampsia is characterized by the following signs and symptoms (",
"       <a class=\"graphic graphic_table graphicRef78675 \" href=\"mobipreview.htm?14/24/14731\">",
"        table 2",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       A pregnant woman should immediately call her healthcare provider if any of the signs or symptoms of severe preeclampsia develop, or if she has decreased fetal activity, vaginal bleeding, abdominal pain, or frequent uterine contractions.",
"      </li>",
"      <li>",
"       The only cure for preeclampsia is delivery of the baby and placenta. Bedrest and taking high blood pressure medication can lower the blood pressure but will not stop preeclampsia from worsening or reduce the risk of its complications.",
"      </li>",
"      <li>",
"       If tests monitoring the mother&rsquo;s or baby's condition show concerning results, the healthcare provider may recommend delivery. A vaginal delivery is often possible.",
"      </li>",
"      <li>",
"       Because women with preeclampsia can develop seizures (called eclampsia), most women are treated with an anticonvulsant medication. Magnesium sulfate is the drug most commonly used to prevent seizures. It is safe for both mother and baby. It is given intravenously to the mother during labor and usually for 24 hours after delivery.",
"      </li>",
"      <li>",
"       High blood pressure and protein in the urine resolve after delivery, usually within a few days. However, some women require medication to reduce high blood pressure after being discharged from the hospital.",
"      </li>",
"      <li>",
"       Most women who experience mild preeclampsia will not have it in a future pregnancy. The risk of recurrence is higher in women with severe preeclampsia, especially when it occurs in the second trimester.",
"      </li>",
"      <li>",
"       Women who develop preeclampsia appear to be at increased risk of developing cardiovascular disease later in life, so regular health care may be particularly important in this group of patients.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804583988\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12644852\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/53/28498?source=see_link\">",
"      Patient information: Preeclampsia (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/42/21155?source=see_link\">",
"      Patient information: Swelling (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/32/7682?source=see_link\">",
"      Patient information: High blood pressure and pregnancy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/46/29410?source=see_link\">",
"      Patient information: HELLP syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/44/1732?source=see_link\">",
"      Patient information: Having twins (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/29/37331?source=see_link\">",
"      Patient information: Prenatal care (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12644860\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/45/11988?source=see_link\">",
"      Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=see_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/26/17832?source=see_link\">",
"      Abnormalities of coagulation and platelet function in preeclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33479?source=see_link\">",
"      Acute kidney injury (acute renal failure) in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=see_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/55/34681?source=see_link\">",
"      Critical illness during pregnancy and the peripartum period",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/55/39801?source=see_link\">",
"      Eclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/2/32808?source=see_link\">",
"      Expectant management of severe preeclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/44/29383?source=see_link\">",
"      Gestational hypertension",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/63/5114?source=see_link\">",
"      Headache in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/30/17897?source=see_link\">",
"      HELLP syndrome",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link\">",
"      Pathogenesis of preeclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11480?source=see_link\">",
"      Prediction of preeclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=see_link\">",
"      Prevention of preeclampsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31992?source=see_link\">",
"      Short-term complications of the premature infant",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Mayo Clinic",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.mayoclinic.com/\">",
"      www.mayoclinic.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/58/40867/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 23, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/58/40867?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40867/abstract/1\">",
"      ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40867/abstract/2\">",
"      Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40867/abstract/3\">",
"      Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287:3183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40867/abstract/4\">",
"      Hall DR, Odendaal HJ, Steyn DW, Grov&eacute; D. Urinary protein excretion and expectant management of early onset, severe pre-eclampsia. Int J Gynaecol Obstet 2002; 77:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f39_58_40867=[""].join("\n");
var outline_f39_58_40867=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS PREECLAMPSIA?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           WOMEN AT RISK FOR PREECLAMPSIA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           PREECLAMPSIA SIGNS AND SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           PREECLAMPSIA MANAGEMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           CARE AFTER DELIVERY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           OUTCOMES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H21\">",
"           RISK OF PREECLAMPSIA IN FUTURE PREGNANCIES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/24/11659\" title=\"table 1\">",
"           Indications for delivery in preeclampsia PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/24/14731\" title=\"table 2\">",
"           Signs and symptoms of severe preeclampsia",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f39_58_40868="Anterior wall MI four chamber echo 3";
var content_f39_58_40868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/63477/4chanmi3_conv.mp4?title=Anterior+wall+MI+four+chamber+echo+3\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior wall myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 275px; height: 441px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Four chamber view from a 2-D echocardiogram shows a large, extensive anterior wall infarction with a dilated left ventricle that is diffusely hypokinetic with regions of akinesis. The myocardium is thin and fails to thicken with systole. Additionally, there is right and left atrial enlargement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40868=[""].join("\n");
var outline_f39_58_40868=null;
var title_f39_58_40869="Valtrac device anastomosis";
var content_f39_58_40869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Valtec device bowel anastomosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: Pursestring suture on proximal and distal ends. Panel B: Placement of Valtrac and ligation of proximal pursestring sutures. Panel C: Ligation of pursestring distally and approximated rings and intact anastomosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40869=[""].join("\n");
var outline_f39_58_40869=null;
var title_f39_58_40870="Predictors of response to hepatitis C treatment in HIV-infected patients";
var content_f39_58_40870=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Predictors of response to hepatitis C treatment in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     Barbara H McGovern, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     David Thomas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40870/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/58/40870/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H20762675\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The consequences of hepatitis C virus (HCV) infection in HIV-infected patients are significant and include accelerated liver disease progression, high rates of end-stage liver disease, and shortened lifespan after hepatic decompensation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/1\">",
"     1",
"    </a>",
"    ]. These observations provide the rationale for treatment consideration in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients.",
"   </p>",
"   <p>",
"    This topic will address the predictors of treatment response to HCV therapy in the HIV-infected patient. The epidemiology, natural history, diagnosis, and treatment of this patient population are discussed elsewhere. Detailed clinical data from pivotal randomized controlled trials are also available for review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38536?source=see_link\">",
"     \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766256\">",
"    <span class=\"h1\">",
"     GENERAL BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goal of therapy is to achieve a sustained virologic response, which is defined as an undetectable HCV RNA six months after the end of treatment. Viral eradication may lead to reduction of morbidity and mortality secondary to liver disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Predictors of treatment response in HIV-infected patients are similar to those reported in patients with HCV alone. The main pretreatment factors include HCV genotype, baseline viral load, and host genetic factors. The main on-treatment predictor of response is the rapidity of the HCV RNA decline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766263\">",
"    <span class=\"h1\">",
"     GENOTYPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most important predictors of outcome is genotype; patients with genotype 2 or 3 infection have higher sustained virologic response rates than patients with genotype 1 or 4 infection (eg, 75 to 80 percent compared with 42 to 46 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. This observation holds true for",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients, where response rates for genotype 2 and 3 infection range from 44 to 73 percent compared with 17 to 29 percent for genotype 1 infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766270\">",
"    <span class=\"h1\">",
"     BASELINE VIRAL LOAD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another important predictor of treatment response is baseline HCV RNA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/7\">",
"     7",
"    </a>",
"    ]. Of note, multiple studies have demonstrated that",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients generally have higher HCV RNA levels than patients with HCV alone, which may contribute to slower rates of viral clearance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/8\">",
"     8",
"    </a>",
"    ]. One study of HCV viral kinetics demonstrated that viral clearance time increased by 28 percent in patients who were also infected with HIV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/8\">",
"     8",
"    </a>",
"    ]. The combination of prevalent high-level viremia and slower clearance in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients may have a significant effect on viral kinetics during treatment.",
"   </p>",
"   <p>",
"    The impact of high-level viremia is most apparent in patients with genotype 1 infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ]. In the APRICOT trial, genotype 1 patients with a baseline viral load of &lt;400,000 int.",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    achieved SVR rates of 71 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/9\">",
"     9",
"    </a>",
"    ]. In contrast, those with baseline viral load of &gt;400,000 int.",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    had SVR rates of only 20 percent. Less disparate outcomes were seen in the genotype non-1 patients, although the impact of viral load was still significant. Those with a baseline viral load of &lt;400,000 int.",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    had SVR rates of 74 percent compared with SVR rates of 59 percent in those with a baseline HCV RNA of &gt;400,000 int.",
"    <span class=\"nowrap\">",
"     units/mL.",
"    </span>",
"   </p>",
"   <p>",
"    One meta-analysis of seven studies, including 784 patients treated with pegylated",
"    <span class=\"nowrap\">",
"     interferon/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"      ribavirin",
"     </a>",
"     ,",
"    </span>",
"    also documented generally lower SVR rates in patients with high HCV RNA levels, defined as &gt;800,000 int.",
"    <span class=\"nowrap\">",
"     units/mL,",
"    </span>",
"    compared with those with lower levels (odds ratio 0.41; 95% CI 0.26-0.61) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766277\">",
"    <span class=\"h1\">",
"     VIRAL LOAD RESPONSE TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral load measurements after the initiation of therapy at various time points give different types of prognostic information about the patient's probability of responding to treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=see_link\">",
"     \"Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=see_link&amp;anchor=H32984769#H32984769\">",
"     \"Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection\", section on 'Changes in viral load during treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766284\">",
"    <span class=\"h2\">",
"     HCV RNA response at 12 weeks",
"    </span>",
"    &nbsp;&mdash;&nbsp;An \"early virologic response\" (EVR) at 12 weeks is defined as either complete viral suppression (complete EVR) or a 2-log drop in viremia (partial EVR).",
"   </p>",
"   <p>",
"    As shown in patients with HCV alone, the absence of an EVR is a powerful negative predictor of a sustained virologic response in HIV-infected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was well illustrated in a multicenter, placebo-controlled trial (RIBAVIC), which compared standard",
"    <span class=\"nowrap\">",
"     interferon/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"      ribavirin",
"     </a>",
"    </span>",
"    to pegylated",
"    <span class=\"nowrap\">",
"     interferon/ribavirin",
"    </span>",
"    in 412",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients. Only 1 percent of patients in this trial who did not achieve either a 2-log drop of HCV RNA or a nondetectable viral load after three months of therapy achieved a sustained virologic response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/5\">",
"     5",
"    </a>",
"    ]. Similar findings were noted in the APRICOT trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38536?source=see_link\">",
"     \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another study of 278",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients demonstrated that the risk of relapse was 11-fold higher among patients who achieved only a 2-log HCV RNA decline compared with those who attained complete viral suppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We use these data to help guide decisions about treatment discontinuation in individual patients. We discontinue therapy in patients who have not achieved a 2-log decline in HCV RNA by 12 weeks of therapy. In those who have achieved only a partial EVR, a full discussion of the low potential of treatment success should be balanced with the severity of liver disease and treatment-related side effects. For example, in a patient with mild disease and severe side effects, a decision may be made to discontinue treatment. In contrast, in a patient with advanced disease who is tolerating therapy well, treatment may be continued with monthly virologic monitoring to assess response at later time points. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36345?source=see_link\">",
"     \"Monitoring the HIV-infected patient taking hepatitis C therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766291\">",
"    <span class=\"h2\">",
"     HCV RNA response at four weeks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attainment of a non-detectable HCV RNA at four weeks is a powerful positive predictor of a sustained virologic response in patients with HCV alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/12\">",
"     12",
"    </a>",
"    ]. The HCV RNA response at four weeks has also been studied in HIV-infected patients with the following observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 289 patients with genotype 1 infection in the APRICOT trial, 22 (13 percent) had a rapid viral load response; 18 of these 22 patients (85 percent) achieved an SVR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 323",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients who were treated with at least one dose of therapy in the RIBAVIC trial, an undetectable HCV RNA level at four weeks had a positive predictive value for an SVR of 98 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although these data suggest that attainment of viral suppression at four weeks is also a powerful predictor of SVR in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients, the vast majority do not achieve this benchmark.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766298\">",
"    <span class=\"h1\">",
"     GENETIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) around the IL28B gene (which codes for IFN-lambda 3), which are strongly associated with treatment-induced viral clearance of genotype 1 infection in HIV-seronegative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/11\">",
"     11",
"    </a>",
"    ]. Similar observations have been made in studies of",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. One modeling study suggested that the probability of achieving an SVR with dual therapy can be reliably estimated prior to initiation of treatment using an index that includes IL-28, liver stiffness (as measured by elastography), HCV genotype and viral load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical utility of testing IL28B genotypes is not yet clear since there are no randomized trial data yet on whether IL28b testing can assist in prospective patient selection for therapeutic intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=see_link&amp;anchor=H16092947#H16092947\">",
"     \"Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection\", section on 'IL28B polymorphisms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    IL28 genotyping can be obtained from LabCorp.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766305\">",
"    <span class=\"h1\">",
"     INSULIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another negative predictor of treatment response in patients with HCV alone is baseline insulin resistance, which may be mediated through host and viral factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HCV infection itself promotes insulin resistance, mainly via increased production of tumor necrosis factor (TNF-alpha) together with enhancement of suppressor of cytokine (SOC-3); both events interfere with downstream interferon signaling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/19\">",
"     19",
"    </a>",
"    ]. Host factors that contribute to insulin resistance include obesity.",
"   </p>",
"   <p>",
"    Several epidemiologic studies have demonstrated a link between HCV infection and insulin",
"    <span class=\"nowrap\">",
"     resistance/diabetes",
"    </span>",
"    in both HCV and",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Some studies suggest that insulin resistance is associated with lower rates of SVR and slower viral clearance in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an observational prospective study of 74 treatment-naive patients, genotype 1 and 4 infection, high baseline HCV RNA levels, and insulin resistance were associated with lower odds of attaining rapid virologic clearance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study examined response rates in 155 patients with or without baseline insulin resistance, (as measured by HOMA) and found no correlation with virologic outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/25\">",
"       25",
"      </a>",
"      ]. However, the study was limited by its retrospective design; furthermore, frozen serum samples were only available on 58 percent of the treated cohort.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766312\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's pretherapy CD4 T cell count has not been clearly associated with virologic outcome, although the data are scant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2,3,5,10,26\">",
"     2,3,5,10,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a subset analysis of 51 patients with CD4+ T-cell counts less than 200",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      who were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/27/27064?source=see_link\">",
"       pegylated interferon alfa-2a",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      in the APRICOT trial, the overall sustained virologic response (SVR) was 47 percent, which was comparable to the 40 percent SVR rate seen in the overall study population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the RIBAVIC, ACTG 5071, and APRICOT trials, CD4+ T-cell counts at baseline were not predictive of SVR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2,3,5\">",
"       2,3,5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38536?source=see_link\">",
"       \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In another study from Spain, although SVR rates were comparable in patients with and without significant immunosuppression, 2 of 39 patients with low CD4 cell counts developed an opportunistic infection during follow-up [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the data on CD4 cell counts as a predictor of SVR are sparse, it is clear that treatment of HCV should not be withheld based on low absolute CD4 cell counts. However, the sequence of therapeutic interventions should include ART before HCV treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/38/18026?source=see_link&amp;anchor=H5443630#H5443630\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\", section on 'Order of HIV and HCV treatment initiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766319\">",
"    <span class=\"h1\">",
"     SUPPRESSOR OF CYTOKINE SIGNALING (SOCS3)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The molecular mechanisms of poor responses to interferon-based therapies are also being explored, including the role of suppressor of cytokine signaling 3 (SOCS3), which may interfere with interferon signaling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/29\">",
"     29",
"    </a>",
"    ]. One study of liver biopsy samples from 49 patients with HCV monoinfection and 22 patients with",
"    <span class=\"nowrap\">",
"     HIV/HCV",
"    </span>",
"    coinfection demonstrated that higher pretreatment hepatic protein expression of SOCS3 was significantly associated with nonresponse to antiviral therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20766326\">",
"    <span class=\"h1\">",
"     OTHER FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other factors that are negative predictors of treatment response in patients with HCV alone have also been associated with lower sustained virological rates among patients with",
"    <span class=\"nowrap\">",
"     HIV/HCV",
"    </span>",
"    coinfection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40870/abstract/31,32\">",
"     31,32",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=see_link\">",
"     \"Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Higher body mass index",
"     </li>",
"     <li>",
"      More advanced fibrosis",
"     </li>",
"     <li>",
"      African American race (compared with Caucasians)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20767240\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The consequences of hepatitis C virus (HCV) infection in HIV-infected patients are significant and include accelerated liver disease progression, high rates of end-stage liver disease, and shortened lifespan after hepatic decompensation. These observations provide the rationale for treatment consideration in",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients. (See",
"      <a class=\"local\" href=\"#H20762675\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary goal of therapy is to achieve a sustained virologic response, which is defined as an undetectable HCV RNA six months after the end of treatment. Predictors of treatment response in HIV-infected patients are similar to those reported in patients with HCV alone. (See",
"      <a class=\"local\" href=\"#H20766256\">",
"       'General background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One of the most important predictors of outcome is genotype; patients with genotype 2 or 3 infection have higher sustained virologic response rates than patients with genotype 1 or 4 infection. (See",
"      <a class=\"local\" href=\"#H20766263\">",
"       'Genotype'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with higher baseline levels of HCV RNA (&gt;400,000",
"      <span class=\"nowrap\">",
"       IU/mL)",
"      </span>",
"      have lower overall sustained virologic response rates compared to those with lower levels of HCV RNA. The impact of high-level viremia is most apparent in patients with genotype 1 infection. (See",
"      <a class=\"local\" href=\"#H20766270\">",
"       'Baseline viral load'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genome-wide association studies have identified several single nucleotide polymorphisms around the IL28B gene (which codes for IFN-lambda 3), which are strongly associated with treatment-induced viral clearance of genotype 1 infection in HIV-seronegative patients. Similar observations have been made in studies of",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients. (See",
"      <a class=\"local\" href=\"#H20766298\">",
"       'Genetic factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The patient's pretherapy CD4 T cell count has not been clearly associated with virologic outcome, although the data are scant. (See",
"      <a class=\"local\" href=\"#H20766312\">",
"       'Immunosuppression'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/1\">",
"      McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 2007; 45 Suppl 2:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/2\">",
"      Chung RT, Andersen J, Volberding P, et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/3\">",
"      Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/4\">",
"      Crespo M, Esteban JI, Ribera E, et al. Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients. AIDS 2007; 21:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/5\">",
"      Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004; 292:2839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/6\">",
"      P&eacute;rez-Olmeda M, N&uacute;&ntilde;ez M, Romero M, et al. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 2003; 17:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/7\">",
"      Fishbein DA, Lo Y, Netski D, et al. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr 2006; 41:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/8\">",
"      Sherman KE, Shire NJ, Rouster SD, et al. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology 2005; 128:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/9\">",
"      Dore GJ, Torriani FJ, Rodriguez-Torres M, et al. Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection. AIDS 2007; 21:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/10\">",
"      Shire NJ, Welge JA, Sherman KE. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis. J Viral Hepat 2007; 14:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/11\">",
"      Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/12\">",
"      Jensen DM, Morgan TR, Marcellin P, et al. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology 2006; 43:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/13\">",
"      Payan C, Pivert A, Morand P, et al. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients. Gut 2007; 56:1111.",
"     </a>",
"    </li>",
"    <li>",
"     Dieterich D, Duff F, Sulkowski M, et al. Sustained virologic response (SVR) in HIV/HCV coinfected patients with HCV genotype 1 infection who have a rapid virologic response at week four of treatment owith peginterferon alfa-2a plus ribavirin. Presented at the 13th annual Conference on Retroviruses and Opportunistic Infections, Denver, CO, February 5-8th, 2006; abstract #856.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/15\">",
"      Rall&oacute;n NI, Naggie S, Benito JM, et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS 2010; 24:F23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/16\">",
"      Pineda JA, Caruz A, Rivero A, et al. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2010; 51:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/17\">",
"      Medrano J, Neukam K, Rall&oacute;n N, et al. Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV. Clin Infect Dis 2010; 51:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/18\">",
"      Romero-G&oacute;mez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/19\">",
"      Romero-G&oacute;mez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12:7075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/20\">",
"      Mehta SH, Moore RD, Thomas DL, et al. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. J Acquir Immune Defic Syndr 2003; 33:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/21\">",
"      Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/22\">",
"      Howard AA, Lo Y, Floris-Moore M, et al. Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS 2007; 21:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/23\">",
"      Nasta P, Gatti F, Puoti M, et al. Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. AIDS 2008; 22:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/24\">",
"      Bongiovanni M, Ranieri R, Casana M, et al. Insulin resistance affects early virologic response in HIV-infected subjects treated for hepatitis C infection. J Acquir Immune Defic Syndr 2008; 47:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/25\">",
"      Merchante N, de los Santos-Gil I, Merino D, et al. Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients. J Hepatol 2009; 50:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/26\">",
"      Valerio L, Yazdanpanah Y, Poizot-Martin I, et al. Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2008; 47:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/27\">",
"      Gholam PM. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients. N Engl J Med 2004; 351:2340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/28\">",
"      Mira JA, Guti&eacute;rrez-Valencia A, Gil Ide L, et al. Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression. Clin Infect Dis 2009; 49:e84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/29\">",
"      Bode JG, Ludwig S, Ehrhardt C, et al. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 2003; 17:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/30\">",
"      Kim KA, Lin W, Tai AW, et al. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J Hepatol 2009; 50:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/31\">",
"      Mira JA, Garc&iacute;a-Rey S, Rivero A, et al. Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Clin Infect Dis 2012; 55:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40870/abstract/32\">",
"      Rozenberg L, Haagmans BL, Neumann AU, et al. Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics. AIDS 2009; 23:2439.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16500 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40870=[""].join("\n");
var outline_f39_58_40870=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20767240\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20762675\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766256\">",
"      GENERAL BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766263\">",
"      GENOTYPE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766270\">",
"      BASELINE VIRAL LOAD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766277\">",
"      VIRAL LOAD RESPONSE TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20766284\">",
"      HCV RNA response at 12 weeks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20766291\">",
"      HCV RNA response at four weeks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766298\">",
"      GENETIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766305\">",
"      INSULIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766312\">",
"      IMMUNOSUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766319\">",
"      SUPPRESSOR OF CYTOKINE SIGNALING (SOCS3)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20766326\">",
"      OTHER FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20767240\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38536?source=related_link\">",
"      Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11848?source=related_link\">",
"      Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41337?source=related_link\">",
"      Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36345?source=related_link\">",
"      Monitoring the HIV-infected patient taking hepatitis C therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14474?source=related_link\">",
"      Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/38/18026?source=related_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_58_40871="Neonatal HSV liver";
var content_f39_58_40871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Liver pathology in disseminated neonatal herpes simplex virus (HSV) infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cross section of liver from a neonate who died of disseminated HSV disease. Liver tissue on gross inspection showed extensive areas of hemorrhage and focal pale areas of necrosis (Panel A). Histopathologic slide (magnification 20X) of liver of a neonate who died of disseminated HSV, showing hepatic necrosis (Panel B). Immunoperoxidase stain specific for HSV antigens shows area of HSV-associated necrosis in reddish brown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Edwina Popek, DO, Department of Pathology, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40871=[""].join("\n");
var outline_f39_58_40871=null;
var title_f39_58_40872="Alexander disease";
var content_f39_58_40872=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Alexander disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Amy T Waldman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Francisco Gonzalez-Scarano, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40872/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/58/40872/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexander disease (MIM #203450) is one of a group of neurologic disorders, collectively referred to as leukodystrophies, that predominantly affect the central nervous system white matter. These disorders are caused by defects in the synthesis (ie, dysmyelination) or maintenance of the myelin sheath that insulates the nerves. While leukodystrophy is the predominant abnormality in the neonatal and infantile forms of Alexander disease, advances in genetics and imaging have revealed a broad phenotypic variability that includes juvenile and adult forms of the disorder without obvious leukodystrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prior to the identification of the genetic features, other names were used to describe the clinical features and pathology of Alexander disease, such as hyaline panneuropathy and dysmyelinogenic leukodystrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2\">",
"     2",
"    </a>",
"    ]. These terms are no longer used.",
"   </p>",
"   <p>",
"    This topic will review the pathology, pathogenesis, clinical features, and diagnosis of Alexander disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexander disease was first described in 1949, when W. Stewart Alexander reported a 15-month-old child with megalencephaly, hydrocephalus, and psychomotor retardation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/3\">",
"     3",
"    </a>",
"    ]. The child died eight months later, and the brain pathology revealed \"a progressive fibrinoid degeneration of fibrillary astrocytes\". These astrocytic inclusions were later found to be identical to Rosenthal fibers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/4\">",
"     4",
"    </a>",
"    ]. The presence of glial fibrillary acidic protein (GFAP) in Rosenthal fibers led to the identification of mutations of the gene encoding GFAP as the cause of Alexander disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Pathogenesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Rosenthal fibers, which are hyaline eosinophilic rods, are present in Alexander disease throughout the central nervous system. These intracytoplasmic astrocytic inclusions are the hallmark of Alexander disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/6\">",
"     6",
"    </a>",
"    ]. They are commonly seen in subpial, subependymal, and perivascular regions. They are present in the perikarya, processes, and end-feet of astrocytes and appear round or oblong, with extensive glial intermediate filaments seen on electron microscopy. They also contain GFAP. In addition, alpha B-crystallin, heat shock protein 27, and ubiquitin are present in Rosenthal fibers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/7-11\">",
"     7-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rosenthal fibers are not specific for Alexander disease; focal Rosenthal fibers are found in other conditions, including astrocytomas, hamartomas, glial scars, and even in multiple sclerosis. However, the focal nature of Rosenthal fibers in these disorders stands in sharp contrast to Alexander disease, where the Rosenthal fibers are diffuse and abundant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Myelin loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    failure of normal myelin development in Alexander disease are variable. In the infantile form, the myelin loss is severe. Patients with juvenile or adult-onset Alexander disease can have mild and patchy myelin loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2001, nonconservative mutations were identified in the regions of chromosome 17q21 that encode the glial fibrillary acidic protein (GFAP) gene from patients representing different Alexander disease phenotypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/5\">",
"     5",
"    </a>",
"    ]. GFAP is an intermediate filament protein found in mature astrocytes that is rapidly synthesized during central nervous system injury and reactive astrogliosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/13\">",
"     13",
"    </a>",
"    ]. Astrocytes also help maintain the blood-brain barrier [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2,12\">",
"     2,12",
"    </a>",
"    ] and have many additional functions.",
"   </p>",
"   <p>",
"    Mutations of the GFAP gene are thought to result in a gain of function phenotype that disrupts dimerization of GFAP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/14\">",
"     14",
"    </a>",
"    ]. This leads to cytoskeletal collapse and abnormal protein aggregation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/15\">",
"     15",
"    </a>",
"    ]. Alternatively, the accumulation of a toxic substance could interrupt filament assembly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/14\">",
"     14",
"    </a>",
"    ]. However, the precise interactions between the GFAP mutations and the cellular responses of astrocytes remain unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexander disease is rare, but its true incidence and prevalence are unknown. Since Alexander's initial description, fewer than 450 patients have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ]. Nevertheless, in a series from Germany, Alexander disease accounted for 1.6 percent of all leukodystrophies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexander disease predominantly affects infants and children, but can affect adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H726209103\">",
"    <span class=\"h2\">",
"     Traditional classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four subtypes of Alexander disease &ndash; neonatal, infantile, juvenile, and adult &ndash; are traditionally recognized. However, the traditional clinical classification of Alexander disease does not predict the disease severity and progression with reliability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Neonatal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neonatal form is associated with increased intracranial pressure, elevated cerebrospinal fluid protein, intractable seizures, severe motor retardation (even in the absence of spasticity), mental retardation, and ataxia. These features reflect involvement of the frontal white matter, basal ganglia, and cerebellum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/18\">",
"     18",
"    </a>",
"    ]. In the neonatal form, death usually occurs within the first few weeks to years of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ], although some affected infants survive until the end of the first decade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Infantile",
"    </span>",
"    &nbsp;&mdash;&nbsp;The infantile form is the most common, accounting for 63 percent of all cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ]. The onset occurs before the age of two [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/19\">",
"     19",
"    </a>",
"    ]. Infants and young children have psychomotor retardation with loss of developmental milestones, spasticity, and feeding difficulties. Affected infants may have head enlargement (macrocephaly) secondary to brain enlargement (megalencephaly), frontal bossing, seizures, and hydrocephalus. Death usually occurs in the first years of life, although some children with infantile-onset Alexander disease survive until the early teenage years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Juvenile",
"    </span>",
"    &nbsp;&mdash;&nbsp;The juvenile phenotype, seen in approximately 24 percent of affected patients, typically presents between ages 4 and 14 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16,20\">",
"     16,20",
"    </a>",
"    ]. It is associated with pseudobulbar and bulbar signs, including swallowing and speech difficulties. Patients may have vomiting, ataxia, spasticity (principally affecting the lower extremities), and kyphoscoliosis. There have been three case reports of children with Alexander disease who presented with symptoms suggestive of anorexia nervosa - failure to thrive, nocturnal vomiting, and weight loss - at ages 6, 7, and 11, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike in the infantile form, children with juvenile Alexander disease are typically normocephalic, and have a slow deterioration of cognitive abilities. Although progressive and fatal, the deterioration is often slower than the infantile form, with survival ranging from 15 months to 12 years in an early report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2\">",
"     2",
"    </a>",
"    ], and to the third and fourth decades in later reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Adult",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult-onset Alexander disease has variable features, including progressive ataxia, and bulbar and pseudobulbar signs such as palatal myoclonus, dysphagia, dysphonia, and dysarthria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16,24-27\">",
"     16,24-27",
"    </a>",
"    ]. Spasticity, quadriparesis, urinary disturbances, and dysautonomia, and dysmorphic features may also be present.",
"   </p>",
"   <p>",
"    In the largest series of 11 cases, onset occurred up to age 62 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Bulbar symptoms, mainly dysarthria, dysphagia, and dysphonia, were the most common, but were infrequent at presentation. Pyramidal involvement, cerebellar ataxia, disturbances of ocular movement (nystagmus, saccadic pursuit, diplopia), palatal myoclonus, sphincter abnormalities, and sleep disorders were also common. Two patients were asymptomatic but were suspected of having Alexander disease after MRI was obtained for other indications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/28\">",
"     28",
"    </a>",
"    ]. Atrophy of the medulla on brain MRI was a characteristic finding.",
"   </p>",
"   <p>",
"    Additional manifestations reported in individual families or cases include dysmorphic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/24\">",
"     24",
"    </a>",
"    ], microcoria (congenital pupillary constriction), endocrine disturbances (amenorrhea and hypothyroidism), mood disturbance, and episodic hypothermia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Imaging abnormalities, particularly in the brainstem and cerebellum, may precede the clinical symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Brain MRI'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The neuroophthalmologic and oculomotor findings reflect dysfunction in the pons and cerebellum, consistent with neuroimaging studies. The adult form may result from a sporadic mutation; however, familial cases have been reported more commonly among adult-onset patients than in the infantile or juvenile forms. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Inheritance'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H726209142\">",
"    <span class=\"h2\">",
"     Revised classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classification of Alexander disease was revised in 2011 on the basis of a statistical method called latent class analysis (LCA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ]. Using data from 215 patients with genetically confirmed Alexander disease, LCA modeling was applied to define clinically coherent subtypes of Alexander disease with similar outcomes. The result suggested that the optimal number of Alexander disease subtypes is two (types I and II). Of note, the LCA models predict trends but do not allow type classification of individual cases with absolute certainty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common features of types I and II are reviewed in the next sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H726209163\">",
"    <span class=\"h3\">",
"     Type I",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I Alexander disease is characterized by the following features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Early onset (often but not always before age four years)",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"     <li>",
"      Macrocephaly",
"     </li>",
"     <li>",
"      Motor delay",
"     </li>",
"     <li>",
"      Encephalopathy",
"     </li>",
"     <li>",
"      Failure to thrive",
"     </li>",
"     <li>",
"      Developmental delay",
"     </li>",
"     <li>",
"      Paroxysmal deterioration",
"     </li>",
"     <li>",
"      Typical neuroimaging features (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Brain MRI'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Type I Alexander disease is generally more severe than type II, with a reduced median survival from onset (14 versus 25 years) and a nearly two-fold increase in mortality for type I compared with type II.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H726209195\">",
"    <span class=\"h3\">",
"     Type II",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type II Alexander disease is characterized by the following features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Manifests across the lifespan, usually but not always age four years or older",
"     </li>",
"     <li>",
"      Autonomic dysfunction",
"     </li>",
"     <li>",
"      Eye movement abnormalities",
"     </li>",
"     <li>",
"      Bulbar symptoms",
"     </li>",
"     <li>",
"      Palatal myoclonus",
"     </li>",
"     <li>",
"      Often lacking neurocognitive or developmental deficits",
"     </li>",
"     <li>",
"      Atypical neuroimaging features (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Atypical neuroimaging features'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, type II Alexander disease is generally less severe and has a longer median survival than type I (see",
"    <a class=\"local\" href=\"#H726209163\">",
"     'Type I'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ninety-seven percent of the cases of Alexander disease are associated with mutations in the coding region of the glial fibrillary acidic protein (GFAP) gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/5,16,31\">",
"     5,16,31",
"    </a>",
"    ]. Over 75 GFAP mutations have been reported in the literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16,30\">",
"     16,30",
"    </a>",
"    ]. In the largest report, an analysis of 215 patients with genetically confirmed Alexander disease, more than one-half of the patients had mutations affecting one of four GFAP peptide sequences (R79, R88, R239, and R416) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ]. An updated list of GFAP mutations associated with Alexander disease is available online from the Waisman Center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sequence analysis detects GFAP mutations in 97 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16\">",
"     16",
"    </a>",
"    ]. Mutations are most commonly found in exons 1, 4, and 6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ]. Mutations in exons 2 and 9 have not yet been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Inheritance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in GFAP usually arise de novo. Most affected individuals with infantile and juvenile onset Alexander disease do not live until child-bearing age and do not reproduce, indicating that the majority of cases are sporadic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, GFAP mutations are seldom detected in parents that have been tested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are some familial cases of Alexander disease, mostly in adults. The adult-onset familial variant is autosomal dominant in inheritance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/16,24,29\">",
"     16,24,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Genotype-phenotype correlations",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned earlier, more than one-half of patients with Alexander disease have mutations affecting one of four GFAP peptide sequences (R79, R88, R239, and R416) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mutations of R79 and R239 GFAP are the most common, and are associated with early onset and with type I Alexander disease (see",
"      <a class=\"local\" href=\"#H726209142\">",
"       'Revised classification'",
"      </a>",
"      above) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"       30",
"      </a>",
"      ]. Earlier studies found that patients with R79 mutations may have a milder clinical course, with some who presented as neonates reported to be alive at ages ranging from 2 to 20 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/32-34\">",
"       32-34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      R239 mutations, specifically R239H and R239C, are associated with more severe phenotypes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30,35\">",
"       30,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      R88 and R416 mutations are not been associated with specific clinical features [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     NEUROIMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral white matter changes are seen with both brain MRI and head CT, but MRI is more sensitive than CT and is therefore the preferred imaging study for patients with a suspected diagnosis of Alexander disease or any leukodystrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Brain MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial frontal abnormalities on MRI in Alexander disease include extensive white matter signal changes and swelling (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51379 \" href=\"mobipreview.htm?25/19/25911\">",
"     image 1",
"    </a>",
"    ). Similarly, the early abnormalities seen in the basal ganglia and thalami include signal abnormalities and swelling (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"     image 2",
"    </a>",
"    ). With time and progression of disease, serial MRI scans demonstrate increasing frontoparietal white matter atrophy with cystic degeneration, enlargement of the lateral ventricles, and atrophy of the basal ganglia and thalami (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74717 \" href=\"mobipreview.htm?16/63/17399\">",
"     image 3",
"    </a>",
"    ). There is relative sparing of occipital and temporal lobe white matter (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51725 \" href=\"mobipreview.htm?2/6/2145\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     MRI criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a report published in 2001, diagnostic criteria for Alexander disease in children based upon brain MRI were proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"     36",
"    </a>",
"    ]. These were derived from three children with autopsy-proven diagnosis, and were retrospectively validated in a cohort of 217 children with leukoencephalopathy of unknown origin.",
"   </p>",
"   <p>",
"    Five MRI criteria were defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extensive cerebral white matter changes with frontal predominance (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51379 \" href=\"mobipreview.htm?25/19/25911\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74717 \" href=\"mobipreview.htm?16/63/17399\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51725 \" href=\"mobipreview.htm?2/6/2145\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74247 \" href=\"mobipreview.htm?9/58/10146\">",
"       image 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A periventricular rim of high signal on T1-weighted sequences and low signal on T2-weighted sequences (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51379 \" href=\"mobipreview.htm?25/19/25911\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74717 \" href=\"mobipreview.htm?16/63/17399\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51725 \" href=\"mobipreview.htm?2/6/2145\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74247 \" href=\"mobipreview.htm?9/58/10146\">",
"       image 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Abnormalities of the basal ganglia and thalami (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51379 \" href=\"mobipreview.htm?25/19/25911\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74717 \" href=\"mobipreview.htm?16/63/17399\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51725 \" href=\"mobipreview.htm?2/6/2145\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74247 \" href=\"mobipreview.htm?9/58/10146\">",
"       image 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Abnormalities of the brainstem, mainly involving the midbrain and medulla (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51725 \" href=\"mobipreview.htm?2/6/2145\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62925 \" href=\"mobipreview.htm?9/43/9907\">",
"       image 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Contrast enhancement involving one or more of the following gray and white matter structures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51379 \" href=\"mobipreview.htm?25/19/25911\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72296 \" href=\"mobipreview.htm?19/51/20279\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74247 \" href=\"mobipreview.htm?9/58/10146\">",
"       image 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53244 \" href=\"mobipreview.htm?27/17/27920\">",
"       image 7",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ventricular lining",
"     </li>",
"     <li>",
"      Periventricular tissue",
"     </li>",
"     <li>",
"      Frontal white matter",
"     </li>",
"     <li>",
"      Optic chiasm",
"     </li>",
"     <li>",
"      Fornix",
"     </li>",
"     <li>",
"      Basal ganglia",
"     </li>",
"     <li>",
"      Thalamus",
"     </li>",
"     <li>",
"      Dentate nucleus",
"     </li>",
"     <li>",
"      Brainstem",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These criteria allow for the diagnosis in infants, in whom the identification of abnormal white matter can be difficult, as well as in patients who do not receive contrast when the MRI is performed. In addition, there is evidence that the MRI imaging pattern encompassed by these criteria is specific for distinguishing Alexander disease from other white matter disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Atypical neuroimaging features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with Alexander disease have atypical or unusual neuroimaging features.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A fetal MRI at 33 weeks gestation showed asymmetrically enlarged ventricles with thickening of the fornices and possible white matter abnormalities. Alexander disease was confirmed after birth by genetic testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one report, 10 patients with juvenile or neonatal-onset Alexander disease and Rosenthal fibers on histologic examination did not meet the previously established MRI criteria for the disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/39\">",
"       39",
"      </a>",
"      ]. In eight of these, MRI showed mainly posterior fossa lesions, particularly multifocal brainstem lesions resembling multiple tumors.",
"     </li>",
"     <li>",
"      In a study of seven patients with juvenile-onset Alexander disease and GFAP mutations, MRI abnormalities (signal change or atrophy) were seen predominantly in the medulla and cervical spinal cord (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62925 \" href=\"mobipreview.htm?9/43/9907\">",
"       image 6",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/40\">",
"       40",
"      </a>",
"      ]. A novel finding was the description of ventricular garlands in four patients.",
"     </li>",
"     <li>",
"      A 12 year old girl with juvenile-onset Alexander disease had focal brainstem and cervical cord lesions without white matter changes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 20 year old man with adult-onset Alexander disease presented with episodic dysphagia and dysphonia, and transient gaze-evoked nystagmus; he later developed diplopia because of a right cranial nerve VI palsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/42\">",
"       42",
"      </a>",
"      ]. Abnormalities on MRI included T2 hyperintensity in the medulla and upper cervical spinal cord, with areas of contrast enhancement and progressive brainstem atrophy on serial scans. In addition, there was a rim of increased periventricular signal with garland-like aspects on fluid-attenuated inversion recovery (FLAIR) and T2-weighted images.",
"     </li>",
"     <li>",
"      In one family, a 26 year old woman presented with a cerebellar mass lesion by head CT, which on biopsy was notable for neuronal loss, gliosis, and Rosenthal fibers characteristic of Alexander disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/43\">",
"       43",
"      </a>",
"      ]. Similarly, her 11 year old brother presented with a brainstem lesion that was found on biopsy to be a manifestation of Alexander disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MRI characteristics appear to vary by age of disease onset. In comparison with the infantile form, the juvenile and adult forms of Alexander disease do not have as clear a predilection for the cerebral white matter.",
"   </p>",
"   <p>",
"    Adults have less frequent supratentorial involvement than juveniles or infants, but the degree of involvement can range from no evidence of cerebral white matter demyelination, to periventricular hyperintensities on T2-weighted and FLAIR sequences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/24,29\">",
"     24,29",
"    </a>",
"    ]. In contrast, adults typically have marked atrophy of the infratentorial structures on brain MRI, most notably involving the medulla, but also involving the remainder of the brainstem, cerebellum, and cervical spinal cord [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/20,28\">",
"     20,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Magnetic resonance spectroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance spectroscopy (MRS) demonstrates abnormalities throughout the brain, supporting the histologic features of glial proliferation, active demyelination, and neuroaxonal degeneration in Alexander disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with infantile Alexander disease, an elevated myoinositol peak may be seen in the white matter, basal ganglia, and cortical gray matter. Myoinositol is a glial-specific marker, and its abundance reflects generalized astrocytosis and glial proliferation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"       44",
"      </a>",
"      ]. However, the absence of this peak does not exclude the diagnosis. In confirmed genetic cases of adult-onset Alexander disease, MRS did not reveal elevated myoinositol [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Choline is increased in the basal ganglia in all patients, with additional elevations in the white and gray matter in some patients. Choline is present in oligodendrocytes, and its presence indicates cell membrane disruption and ongoing demyelination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The reduction in N-acetylaspartylglutamate (NAAG) is most significant in the frontal white matter, but the peaks in the cerebellar white matter and cortical and subcortical gray matter are also diminished. The decreased signals are believed to correspond to neuroaxonal loss [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Elevated lactate has been reported in the frontal white matter, parietal white matter, and basal ganglia, supporting cell death as the underlying process [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"       44",
"      </a>",
"      ]. In addition, serial MRS studies obtained every 14 days for a neonate with Alexander disease showed progressive lactate elevation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/19\">",
"       19",
"      </a>",
"      ]. The lactate may be a byproduct of anaerobic metabolism of infiltrating macrophages or non-oxidative glycolysis in disordered astrocytes, but is a more nonspecific marker [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Alexander disease can be established based upon clinical and radiographic (MRI) features. In addition, the diagnosis is confirmed by demonstrating a GFAP gene mutation. Although genetic testing is not necessarily required for the diagnosis, genetic confirmation should always be attempted due to the heterogeneity of the disease and its presentation. Genetic analysis is available commercially [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children with typical clinical features of Alexander disease, the diagnosis can be established by brain MRI if patients fulfill four of the five MRI diagnostic criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'MRI criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    These MRI criteria remain useful for proving the diagnosis in situations in which genetic testing is equivocal (eg, discovery of novel GFAP sequence variants that are potentially uncommon benign polymorphisms rather than causative mutations). However, MRI criteria alone cannot exclude the diagnosis in children with atypical imaging features, and are not helpful for confirming or refuting the diagnosis in adults. Therefore, when Alexander disease is suspected in adults or in children with atypical imaging features, the diagnosis is confirmed by genetic testing.",
"   </p>",
"   <p>",
"    Demonstration of Rosenthal fibers on brain biopsy or at autopsy is diagnostic, but has been superseded by the availability of MRI and genetic testing.",
"   </p>",
"   <p>",
"    Other laboratory studies are not useful for the diagnosis of Alexander disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;While prenatal diagnosis for adult-onset Alexander disease is theoretically available through amniocentesis and chorionic villus sampling, the affected allele within a family member must be known. A mutation of GFAP has never been identified in an asymptomatic parent of a child with infantile or juvenile Alexander disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. In a family with adult-onset, autosomal dominant transmission of a GFAP mutation, one child with the same genetic mutation developed symptoms before the age of 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of Alexander disease involves consideration of other disorders that present with macrocephaly",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cerebral white matter changes (",
"    <a class=\"graphic graphic_algorithm graphicRef65871 \" href=\"mobipreview.htm?23/14/23785\">",
"     algorithm 1",
"    </a>",
"    ). While many of these disorders share some of the clinical or neuroimaging characteristics of Alexander disease, none shares all of them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, they can be distinguished from Alexander disease by MRI criteria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinical criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adrenoleukodystrophy is an X-linked disorder. Brain MRI of symptomatic boys demonstrates mild to severe cerebral white matter demyelination. Lesions are usually bilateral, with predominant involvement of the frontal lobes, but the occipitoparietal region is typically affected as well. Disease progression correlates with the presence of contrast enhancement on T1-weighted MR images. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33673?source=see_link\">",
"       \"Adrenoleukodystrophy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Canavan disease is a neurodegenerative disease characterized by leukodystrophy and spongy degeneration of the brain. It is caused by a deficiency of aspartoacylase, which leads to increased N-acetylaspartic acid (NAA) levels in the brain. Clinical onset is typically in early infancy with macrocephaly, hypotonia and optic atrophy. Later, hypertonia, seizures, and progressive neurologic deterioration occur. On neuroimaging, there is diffuse cerebral white matter degeneration without a frontal predominance. Unlike Alexander disease, there is no contrast enhancement. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/36/12873?source=see_link\">",
"       \"Aspartoacylase deficiency (Canavan disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Megalencephalic leukoencephalopathy with subcortical cysts presents with macrocephaly in the first year of life [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. Other symptoms include mild developmental delay, ataxia, spasticity, and seizures. Cognition is relatively spared. The disorder is caused by mutations in the MLC1 and HEPACAM genes. MRI reveals diffuse supratentorial white matter abnormalities, edema, and cystic brain lesions, mostly in the frontoparietal border zone region and anterior-temporal subcortical white matter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/47\">",
"       47",
"      </a>",
"      ]. In contrast, the cysts in Alexander disease are mostly located in the deep frontal white matter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease that is usually caused by decreased levels of the enzyme arylsulfatase A and is divided into late infantile, early and late juvenile, and adult forms. As the disease progresses, bulbar symptoms, spasticity, quadriparesis, and optic atrophy occur. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/27/42421?source=see_link\">",
"       \"Metachromatic leukodystrophy\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      On MRI, the cerebral white matter is diffusely and symmetrically hyperintense on T2-weighted images, with a frontal predominance. Unlike Alexander disease, contrast enhancement on neuroimaging is not associated with MLD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"       36",
"      </a>",
"      ]. The presence of a demyelinating peripheral neuropathy, which is usually present in the late infantile or juvenile forms, also distinguishes MLD from Alexander disease.",
"     </li>",
"     <li>",
"      Classic (merosin deficient) congenital muscular dystrophy is associated with demyelination of the cerebral hemispheres without structural central nervous system anomalies. MRI shows extensive cerebral white matter changes, but the occipital white matter is relatively spared [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/14/41192?source=see_link&amp;anchor=H16#H16\">",
"       \"Oculopharyngeal, distal, and congenital muscular dystrophies\", section on 'Congenital muscular dystrophies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adult-onset Alexander disease can mimic multiple sclerosis (MS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/50\">",
"       50",
"      </a>",
"      ], a central nervous system demyelinating disorder. Patients with MS frequently have gait disturbances, ataxia, visual changes, and autonomic dysfunction, with a relapsing and remitting course. Lesions on the MRI are typically periventricular and asymmetric. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32458?source=see_link\">",
"       \"Epidemiology and clinical features of multiple sclerosis in adults\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      As an example, the first patient with histologically proven adult-onset Alexander disease was initially diagnosed with MS. At age 32, he developed left arm paralysis for five days, which improved with time to only mild weakness. His other symptoms waxed and waned, including diplopia, difficulty walking, impaired proprioception, and occasional lightheadedness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/51\">",
"       51",
"      </a>",
"      ]. This patient had three daughters, and all had progressive palatal myoclonus, spastic weakness, hyperreflexia, mild cerebellar dysfunction, and ocular motor abnormalities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/52\">",
"       52",
"      </a>",
"      ]. The autopsy of one daughter revealed widespread Rosenthal fiber deposition and demyelination, consistent with Alexander disease.",
"     </li>",
"     <li>",
"      Organic acidemias are characterized by the excretion of non-amino organic acids in urine, from defective amino acid catabolism. They vary in severity and age of onset. The neonatal variants, such as isovaleric acidemia and maple syrup urine disease, present in the first few days of life with vomiting, poor feeding, seizures, hypotonia, and lethargy. Glutaric acidemia type I and L-2 hydroxyglutaric aciduria may present with accelerated head growth. In the older child or adolescent, affected individuals can have loss of intellectual function, ataxia, or other focal neurologic signs. MRI abnormalities have been described in the white matter and basal ganglia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7914?source=see_link\">",
"       \"Organic acidemias\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of Alexander disease remains supportive. Antiepileptic drugs are used to control seizures. In the neonatal and infantile forms associated with hydrocephalus, a ventriculoperitoneal shunt may be required.",
"   </p>",
"   <p>",
"    One adult with Alexander disease demonstrated clinical stabilization after prolonged treatment with intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/53\">",
"     53",
"    </a>",
"    ]. However, the mechanism of action and utility of beta lactams this setting has not been clearly elucidated and requires further investigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40872/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexander disease (MIM #203450) is a rare genetic disorder that predominantly affects infants and children and is associated with cerebral white matter disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracytoplasmic astrocytic inclusions known as Rosenthal fibers are the hallmark of Alexander disease. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sporadic mutations in the GFAP gene are the cause of most cases of Alexander disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Four subtypes of Alexander disease &mdash; neonatal, infantile, juvenile, and adult &mdash; are traditionally recognized (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The neonatal form is associated with increased intracranial pressure, seizures, severe motor retardation, and ataxia",
"     </li>",
"     <li>",
"      The infantile form is characterized by megalencephaly, frontal bossing, seizures, hydrocephalus, psychomotor retardation with loss of developmental milestones, spasticity, and feeding difficulties",
"     </li>",
"     <li>",
"      Children with juvenile Alexander disease are typically normocephalic, and the deterioration is often slower than the infantile form",
"     </li>",
"     <li>",
"      Adult-onset Alexander disease has variable features",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A revised classification of Alexander disease proposes two subtypes &ndash; types I and II &ndash; based upon statistical analyses (see",
"      <a class=\"local\" href=\"#H726209142\">",
"       'Revised classification'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Type I is characterized by early onset, seizures, macrocephaly, motor delay, encephalopathy, sudden deterioration, and typical neuroimaging features",
"     </li>",
"     <li>",
"      Type II onset may occur across the lifespan, and is characterized by autonomic dysfunction, eye movement abnormalities, bulbar symptoms, and atypical neuroimaging features",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Typical MRI features of Alexander disease are as follows (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Brain MRI'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Extensive cerebral white matter changes with frontal predominance",
"     </li>",
"     <li>",
"      Periventricular rim of high T1 signal and low T2 signal",
"     </li>",
"     <li>",
"      Basal ganglia and thalamic abnormalities",
"     </li>",
"     <li>",
"      Brainstem abnormalities",
"     </li>",
"     <li>",
"      Contrast enhancement of selected gray and white matter structures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Less common MRI features of Alexander disease include (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Brain MRI'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Multifocal brainstem lesions resembling multiple tumors",
"     </li>",
"     <li>",
"      Medullary and cervical spinal cord signal abnormalities or atrophy",
"     </li>",
"     <li>",
"      Ventricular garlands",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of Alexander disease can be established based upon clinical and radiographic (MRI) features. The diagnosis is usually confirmed by demonstrating a GFAP gene mutation. Although genetic testing is not necessarily required for the diagnosis, genetic confirmation should always be attempted due to the heterogeneity of the disease and its presentation. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of Alexander disease involves consideration of other disorders that present with macrocephaly",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cerebral white matter changes. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of Alexander disease remains supportive. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/1\">",
"      Barkovich AJ, Messing A. Alexander disease: not just a leukodystrophy anymore. Neurology 2006; 66:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/2\">",
"      Russo LS Jr, Aron A, Anderson PJ. Alexander's disease: a report and reappraisal. Neurology 1976; 26:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/3\">",
"      ALEXANDER WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 1949; 72:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/4\">",
"      Rosenthal, W. &Uuml;ber eine eigenth&uuml;mliche, mit syringomyelie complicirte geschwulst des r&uuml;ckenmarks. Bietr Pathol Anat 1898; 23:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/5\">",
"      Brenner M, Johnson AB, Boespflug-Tanguy O, et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27:117.",
"     </a>",
"    </li>",
"    <li>",
"     Fenichel, GM. Clinical pediatric neurology: a signs and symptoms approach, 5th Ed, Philadelphia 2005. p.133.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/7\">",
"      Iwaki T, Kume-Iwaki A, Liem RK, Goldman JE. Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 1989; 57:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/8\">",
"      Tomokane N, Iwaki T, Tateishi J, et al. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am J Pathol 1991; 138:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/9\">",
"      Iwaki A, Iwaki T, Goldman JE, et al. Accumulation of alpha B-crystallin in brains of patients with Alexander's disease is not due to an abnormality of the 5'-flanking and coding sequence of the genomic DNA. Neurosci Lett 1992; 140:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/10\">",
"      Head MW, Corbin E, Goldman JE. Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am J Pathol 1993; 143:1743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/11\">",
"      Head MW, Goldman JE. Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathol Appl Neurobiol 2000; 26:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/12\">",
"      Johnson AB, Brenner M. Alexander's disease: clinical, pathologic, and genetic features. J Child Neurol 2003; 18:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/13\">",
"      Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000; 25:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/14\">",
"      Li R, Messing A, Goldman JE, Brenner M. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002; 20:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/15\">",
"      Nielsen AL, J&oslash;rgensen P, J&oslash;rgensen AL. Mutations associated with a childhood leukodystrophy, Alexander disease, cause deficiency in dimerization of the cytoskeletal protein GFAP. J Neurogenet 2002; 16:175.",
"     </a>",
"    </li>",
"    <li>",
"     Gorospe JR. Alexander disease. In: GeneReviews [Internet]. www.ncbi.nlm.nih.gov/books/NBK1172/ (Accessed on October 05, 2011).",
"    </li>",
"    <li>",
"     Garbern, JY. Leukodystrophies. In: Neurogenetics: Clinical and Scientific Advances, Lynch, DR (Ed), Taylor and Francis, New York 2005. p.469.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/18\">",
"      Springer S, Erlewein R, Naegele T, et al. Alexander disease--classification revisited and isolation of a neonatal form. Neuropediatrics 2000; 31:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/19\">",
"      Bassuk AG, Joshi A, Burton BK, et al. Alexander disease with serial MRS and a new mutation in the glial fibrillary acidic protein gene. Neurology 2003; 61:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/20\">",
"      Kinoshita T, Imaizumi T, Miura Y, et al. A case of adult-onset Alexander disease with Arg416Trp human glial fibrillary acidic protein gene mutation. Neurosci Lett 2003; 350:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/21\">",
"      Van Poppel K, Broniscer A, Patay Z, Morris EB. Alexander disease: An important mimicker of focal brainstem glioma. Pediatr Blood Cancer 2009; 53:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/22\">",
"      Niinikoski H, Haataja L, Brander A, et al. Alexander disease as a cause of nocturnal vomiting in a 7-year-old girl. Pediatr Radiol 2009; 39:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/23\">",
"      Franzoni E, Van der Knaap MS, Errani A, et al. Unusual diagnosis in a child suffering from juvenile Alexander disease: clinical and imaging report. J Child Neurol 2006; 21:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/24\">",
"      Stumpf E, Masson H, Duquette A, et al. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Arch Neurol 2003; 60:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/25\">",
"      Martidis A, Yee RD, Azzarelli B, Biller J. Neuro-ophthalmic, radiographic, and pathologic manifestations of adult-onset Alexander disease. Arch Ophthalmol 1999; 117:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/26\">",
"      Sreedharan J, Shaw CE, Jarosz J, Samuel M. Alexander disease with hypothermia, microcoria, and psychiatric and endocrine disturbances. Neurology 2007; 68:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/27\">",
"      Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008; 131:2321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/28\">",
"      Farina L, Pareyson D, Minati L, et al. Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol 2008; 29:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/29\">",
"      Okamoto Y, Mitsuyama H, Jonosono M, et al. Autosomal dominant palatal myoclonus and spinal cord atrophy. J Neurol Sci 2002; 195:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/30\">",
"      Prust M, Wang J, Morizono H, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 2011; 77:1287.",
"     </a>",
"    </li>",
"    <li>",
"     GFAP mutations associated with Alexander disease. Waisman Center, University of Wisconsin-Madison. www.waisman.wisc.edu/alexander-disease/mutation-table.pdf (Accessed on October 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/32\">",
"      Rodriguez D, Gauthier F, Bertini E, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet 2001; 69:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/33\">",
"      Gorospe JR, Naidu S, Johnson AB, et al. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 2002; 58:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/34\">",
"      Meins M, Brockmann K, Yadav S, et al. Infantile Alexander disease: a GFAP mutation in monozygotic twins and novel mutations in two other patients. Neuropediatrics 2002; 33:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/35\">",
"      Li R, Johnson AB, Salomons G, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005; 57:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/36\">",
"      van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/37\">",
"      van der Knaap MS, Breiter SN, Naidu S, et al. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999; 213:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/38\">",
"      V&aacute;zquez E, Macaya A, Mayolas N, et al. Neonatal Alexander disease: MR imaging prenatal diagnosis. AJNR Am J Neuroradiol 2008; 29:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/39\">",
"      van der Knaap MS, Salomons GS, Li R, et al. Unusual variants of Alexander's disease. Ann Neurol 2005; 57:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/40\">",
"      van der Knaap MS, Ramesh V, Schiffmann R, et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology 2006; 66:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/41\">",
"      Probst EN, Hagel C, Weisz V, et al. Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol 2003; 53:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/42\">",
"      Romano S, Salvetti M, Ceccherini I, et al. Brainstem signs with progressing atrophy of medulla oblongata and upper cervical spinal cord. Lancet Neurol 2007; 6:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/43\">",
"      Duckett S, Schwartzman RJ, Osterholm J, et al. Biopsy diagnosis of familial Alexander's disease. Pediatr Neurosurg 1992; 18:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/44\">",
"      Brockmann K, Dechent P, Meins M, et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 2003; 250:300.",
"     </a>",
"    </li>",
"    <li>",
"     Alexander disease. Gene Tests. www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/56683?db=genetests (Accessed on October 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/46\">",
"      Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009; 72:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/47\">",
"      van der Knaap MS, Barth PG, Stroink H, et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995; 37:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/48\">",
"      van der Knaap MS, Boor I, Est&eacute;vez R. Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis. Lancet Neurol 2012; 11:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/49\">",
"      van der Knaap MS, Smit LM, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997; 42:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/50\">",
"      Brockmann K, Meins M, Taubert A, et al. A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease? Eur Neurol 2003; 50:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/51\">",
"      Seil FJ, Schochet SS Jr, Earle KM. Alexander's disease in an adult. Report of a case. Arch Neurol 1968; 19:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/52\">",
"      Schwankhaus JD, Parisi JE, Gulledge WR, et al. Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology 1995; 45:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/53\">",
"      Sechi G, Matta M, Deiana GA, et al. Ceftriaxone has a therapeutic role in Alexander disease. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/54\">",
"      Rothstein JD, Patel S, Regan MR, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40872/abstract/55\">",
"      Lipski J, Wan CK, Bai JZ, et al. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 2007; 146:617.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1695 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-9D3D6B0F7E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40872=[""].join("\n");
var outline_f39_58_40872=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H726209103\">",
"      Traditional classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Neonatal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Infantile",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Juvenile",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Adult",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H726209142\">",
"      Revised classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H726209163\">",
"      - Type I",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H726209195\">",
"      - Type II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Inheritance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Genotype-phenotype correlations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      NEUROIMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Brain MRI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - MRI criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Atypical neuroimaging features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Magnetic resonance spectroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1695\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1695|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?23/14/23785\" title=\"algorithm 1\">",
"      MRI algorithm white matter disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1695|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?25/19/25911\" title=\"diagnostic image 1\">",
"      Brain MRI ages 1 and 3 months infantile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/51/20279\" title=\"diagnostic image 2\">",
"      Brain MRI age 4 months infantile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?16/63/17399\" title=\"diagnostic image 3\">",
"      Brain MRIs ages 20 mo and 9 yrs juvenile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?2/6/2145\" title=\"diagnostic image 4\">",
"      Brain MRI age 4 years juvenile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/58/10146\" title=\"diagnostic image 5\">",
"      Brain MRI age 10 years juvenile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/43/9907\" title=\"diagnostic image 6\">",
"      Brain MRI age 13 years juvenile Alexander disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/17/27920\" title=\"diagnostic image 7\">",
"      Brain MRI age 12 years juvenile Alexander disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33673?source=related_link\">",
"      Adrenoleukodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/36/12873?source=related_link\">",
"      Aspartoacylase deficiency (Canavan disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/27/42421?source=related_link\">",
"      Metachromatic leukodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/14/41192?source=related_link\">",
"      Oculopharyngeal, distal, and congenital muscular dystrophies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7914?source=related_link\">",
"      Organic acidemias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_58_40873="Combined immunodeficiencies";
var content_f39_58_40873=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Combined immunodeficiencies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     Francisco A Bonilla, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/58/40873/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/58/40873/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several genetic mutations lead to variable immune defects of humoral and cell-mediated immunity (",
"    <a class=\"graphic graphic_table graphicRef64286 \" href=\"mobipreview.htm?14/41/15006\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/1\">",
"     1",
"    </a>",
"    ]. Combined immunodeficiency syndromes are somewhat arbitrarily distinguished from severe combined immunodeficiency (SCID) in that they do not characteristically lead to death from overwhelming infection in the first year of life. In addition, combined immunodeficiency syndromes frequently have associated clinical features.",
"   </p>",
"   <p>",
"    Mutations of a particular gene may lead to severe combined immunodeficiency (SCID) or to milder combined immunodeficiency, depending upon whether the gene defect is fully penetrant or on the functional consequences of the specific mutation: amorphic (complete defect) or hypomorphic (partial defect). Genetic defects in which the mutations primarily lead to a SCID phenotype are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"     \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following combined immunodeficiency syndromes are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      CD40 and CD40 ligand deficiencies (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/32/21001?source=see_link\">",
"       \"Hyperimmunoglobulin M syndromes\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Wiskott-Aldrich syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"       \"Wiskott-Aldrich syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ataxia-telangiectasia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=see_link\">",
"       \"Ataxia-telangiectasia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      DiGeorge syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15608?source=see_link\">",
"       \"DiGeorge syndrome: Management and prognosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nijmegen breakage syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=see_link\">",
"       \"Nijmegen breakage syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Purine nucleoside phosphorylase deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/27/2488?source=see_link\">",
"       \"Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      DNA ligase IV deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20362?source=see_link\">",
"       \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cernunnos deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20362?source=see_link\">",
"       \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Omenn syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20362?source=see_link\">",
"       \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Zeta chain-associated protein 70 (ZAP-70) deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/2/42022?source=see_link\">",
"       \"ZAP-70 deficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      T cell receptor alpha subunit constant (TRAC) deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"       \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      CD3 gamma chain deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"       \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lymphocyte-specific protein-tyrosine kinase (p56lck) deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"       \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      MHC class I and II deficiencies (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"       \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      MyD88 deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Interleukin-1 receptor-associated kinase 4 (IRAK4) deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      UNC93B1 deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      TLR3 deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      X-linked lymphoproliferative syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33384?source=see_link\">",
"       \"X-linked lymphoproliferative disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cartilage-hair",
"      <span class=\"nowrap\">",
"       hypoplasia/short",
"      </span>",
"      limbed dwarfism (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=see_link\">",
"       \"Cartilage-hair hypoplasia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Syndromic immunodeficiencies (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/22/40295?source=see_link\">",
"       \"Syndromic immunodeficiencies\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following disorders are described here:",
"   </p>",
"   <p>",
"    SCID variants",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Interleukin-2 receptor alpha chain (CD25) deficiency",
"     </li>",
"     <li>",
"      Signal transducer and activator of transcription 5b (STAT5b) deficiency",
"     </li>",
"     <li>",
"      Winged-helix nude (FOXN1) deficiency",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       ORAI1/CRACM1",
"      </span>",
"      and STIM1 deficiencies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Defects of NF-kappa-B regulation",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NEMO and I-kappa-B alpha deficiencies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      WHIM syndrome",
"     </li>",
"     <li>",
"      Serine threonine kinase 4",
"      <span class=\"nowrap\">",
"       (STK4/MST1)",
"      </span>",
"      deficiency",
"     </li>",
"     <li>",
"      Caspase-8 deficiency",
"     </li>",
"     <li>",
"      CD8 deficiency",
"     </li>",
"     <li>",
"      CD27 deficiency",
"     </li>",
"     <li>",
"      Dedicator of cytokinesis 8 (DOCK8) deficiency",
"     </li>",
"     <li>",
"      Hypomorphic RAG1 and RAG2 mutations",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined T and B cell immunodeficiencies are rare disorders. The severity of the immunodeficiency and the spectrum of associated abnormalities depend upon which gene is mutated and the extent of the genetic defect. Thus, each syndrome associated with a particular gene(s) can have a wide variation in clinical manifestations and the age at presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with combined immunodeficiency often present in the first two years of life with recurrent infections and specific findings associated with the different syndromes. However, patients with milder defects may not present until later in childhood or even early adulthood.",
"   </p>",
"   <p>",
"    Combined immunodeficiencies may not be identified by SCID newborn screening if thymic output is only mildly or moderately depressed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/30/42471?source=see_link&amp;anchor=H6#H6\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Newborn screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of combined immunodeficiency should be suspected in children with any of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic or recurrent respiratory tract infections (eg, more than eight upper respiratory tract infections or more than one lower respiratory tract infection yearly)",
"     </li>",
"     <li>",
"      Chronic viral disease",
"     </li>",
"     <li>",
"      Opportunistic infections",
"     </li>",
"     <li>",
"      Failure to thrive",
"     </li>",
"     <li>",
"      Chronic diarrhea",
"     </li>",
"     <li>",
"      A family history of immunodeficiency",
"     </li>",
"     <li>",
"      Chronic lymphopenia (total lymphocyte count &lt;1500 cells",
"      <span class=\"nowrap\">",
"       /microL)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the conditions and infections that should alert a clinician to the possibility of immunodeficiency in general is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"     \"Approach to the child with recurrent infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient suspected of having combined immunodeficiency requires complete evaluation of specific humoral and cellular immunity. Studies include the measurement of immunoglobulin levels, specific antibody titers, absolute numbers and percentages of lymphocyte subsets (T, B, and NK), and assessment of T cell function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many of the combined immunodeficiency syndromes have characteristic associated clinical and laboratory features that suggest a particular defect and help direct the diagnostic evaluation. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eczema and thrombocytopenia in Wiskott-Aldrich syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"       \"Wiskott-Aldrich syndrome\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Conical or absent teeth, frontal bossing, fine sparse hair, and hypohidrosis in defects of NF-kappa-B signaling (see",
"      <a class=\"local\" href=\"#H18\">",
"       'Defects of NF-kappa-B regulation'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Cardiac and facial anomalies in DiGeorge syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Warts and neutropenia in WHIM syndrome (see",
"      <a class=\"local\" href=\"#H28\">",
"       'Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Neurologic abnormalities and oculocutaneous telangiectasias in ataxia-telangiectasia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=see_link\">",
"       \"Ataxia-telangiectasia\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Short stature, short limbs, other skeletal anomalies, and fine hair in Cartilage-hair hypoplasia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=see_link\">",
"       \"Cartilage-hair hypoplasia\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Many patients with complete or incomplete DiGeorge syndrome and mucocutaneous candidiasis have antibody defects in addition to their cellular immune deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22553?source=see_link\">",
"       \"Chronic mucocutaneous candidiasis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Clinical features that suggest a genetic syndrome with undue susceptibility to infection (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/22/40295?source=see_link\">",
"       \"Syndromic immunodeficiencies\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is often useful to determine the genetic defect, since it influences the clinical phenotype and may impact the course of the disease and its treatment. It is most important to recognize if a child has one of the defects associated with severe combined immunodeficiency (SCID), as this would require urgent clinical intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of treatment depends upon the type and severity of the immune defect. Live vaccines and nonirradiated blood transfusions should be avoided. Immune globulin is given to patients with antibody deficiency. Patients with increased susceptibility to opportunistic bacterial or other infections are treated with prophylactic antimicrobial agents. Aggressive antimycobacterial therapy and sometimes interferon gamma, are used in patients with increased susceptibility to mycobacterial infections. Hematopoietic cell transplantation, or possibly gene therapy, is indicated for defects that lead to a more severe clinical phenotype and fatality in early childhood if untreated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/52/2889?source=see_link\">",
"     \"Prophylaxis against Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4297?source=see_link\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SCID VARIANTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Interleukin-2 receptor alpha chain (CD25) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least three patients have been described with lesions in the IL2RA gene located on chromosome 10p15.1 (MIM 147730) encoding the alpha chain (CD25) of the IL-2 receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. One patient had an increased susceptibility to bacterial, viral, and fungal infections due to a homozygous mutation in the IL2RA gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Another patient had a phenotype resembling the syndrome of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX), a syndrome which is more often associated with mutations of the transcription factor FOXP3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/15/25850?source=see_link\">",
"     \"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The interleukin-2 (IL-2) receptor alpha and beta chains combine with the common gamma chain to form the high affinity IL-2 receptor (IL-2R) on T cells, B cells, natural killer (NK) cells, and monocytes. IL-2 production and expression of IL-2R are stimulated by antigen binding to the T cell receptor. IL-2 is involved in the growth and differentiation of cytotoxic and regulatory T cells and natural killer cells, and optimization of T cell help to B cells for antibody production. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31098?source=see_link\">",
"     \"Normal B and T lymphocyte development\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The described SCID-like patient presented at six months of age with cytomegalovirus pneumonia and persistent oral and esophageal candidiasis. He had failure to thrive, partly due to chronic diarrhea from adenoviral gastroenteritis. He developed extensive infiltration and inflammation of several tissues with autoreactive T cells. Lymphadenopathy and hepatosplenomegaly became more prominent with age. He had extremely few T and B cells in the circulation, and the T cells did not respond to mitogens in vitro. He underwent successful allogeneic hematopoietic cell transplantation at three years of age.",
"   </p>",
"   <p>",
"    The reported IPEX-like patient had onset of chronic diarrhea and diabetes mellitus and CMV pneumonia at six weeks of age. Serum immunoglobulins were elevated and lymphocyte populations initially appeared normal. Over the ensuing eight years, he exhibited asthma, recurrent otitis media, sinusitis and pneumonia, eczema, lymphadenopathy and hepatosplenomegaly, hypothyroidism, and autoimmune anemia and neutropenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Signal transducer and activator of transcription 5b (STAT5b) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several patients have been identified with mutations in the STAT5B gene that cause a defect in the signaling pathways of receptors for IL-2, IL-4, CSF1 (also called macrophage colony stimulating factor or M-CSF), and growth hormone (MIM 245590) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/6-12\">",
"     6-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CD4+CD25+ regulatory T cells are decreased in number in patients with STAT5b deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Other immunologic parameters are variable, including T, B, and NK cell levels, and T cell proliferation.",
"   </p>",
"   <p>",
"    Patients present with signs of growth hormone insensitivity, including short stature, a prominent forehead and saddle nose, and a high-pitched voice. Some patients also have pruritic skin lesions; one patient was diagnosed with eczema and another with congenital ichthyosis. Manifestations of the associated immunodeficiency include recurrent respiratory tract infections, viral infections (including hemorrhagic varicella and herpes zoster), and Pneumocystis jirovecii (P. carinii) pneumonia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Winged-helix nude (FOXN1) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two sisters were described who had congenital alopecia, nail dystrophy, and severe infections consistent with T cell immunodeficiency (MIM 601705) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/13\">",
"     13",
"    </a>",
"    ]. They had a homozygous defect in the forkhead box N1 (FOXN1) gene, which is the gene mutated in \"nude\" SCID mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Forkhead box N1 (FOXN1, also called winged-helix nude) is a member of the winged-helix domain family of transcription factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/15\">",
"     15",
"    </a>",
"    ]. This protein is involved in the development of the thymus as well as formation of hair and nails. It also may be involved in brain and neural tube development.",
"   </p>",
"   <p>",
"    The two sisters with defects in this gene had decreased circulating T cells, mainly due to low levels of CD4+ T cells. T cell proliferative responses to mitogens were abnormal. One of the sisters died from infection at one year of age. The other was successfully transplanted at five months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/14\">",
"     14",
"    </a>",
"    ]. Four additional children from the same village were identified who had congenital alopecia and died in early childhood from severe infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/16\">",
"     16",
"    </a>",
"    ]. A fetus with the same genetic defect was identified during population screening in the village [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/15\">",
"     15",
"    </a>",
"    ]. This fetus lacked a thymus and had grossly abnormal skin. It also had additional defects, including spina bifida and anencephaly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     ORAI1/CRACM1 and STIM1 deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocyte activation after antigen stimulation is dependent upon store-operated entry of Ca2+ (eg, entry triggered by intracellular depletion of Ca2+) across the plasma membrane via Ca2+ release-activated Ca2+ (CRAC) channels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/17\">",
"     17",
"    </a>",
"    ]. Orai1 or calcium release-activated calcium modulator 1 (CRACM1) is the pore-forming subunit of the CRAC channel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/18\">",
"     18",
"    </a>",
"    ]. Stromal interaction molecule 1 (STIM1) senses release of Ca2+ from endoplasmic reticulum stores and activates CRAC channels in the plasma membrane. Sustained Ca2+ influx leads to translocation of the transcription factor NFAT (nuclear factor of activated T-cells) to the nucleus where it induces expression of IL-2 and other cytokines.",
"   </p>",
"   <p>",
"    Mutations in ORAI1 on chromosome 12q24 (MIM 612782) and STIM1 on chromosome 11q15.5 (MIM 605921) lead to a primary immunodeficiency with increased susceptibility to bacterial and viral infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. Both mutations appear to have autosomal recessive inheritance.",
"   </p>",
"   <p>",
"    The laboratory findings are similar for both of these defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Lymphocyte counts are normal to slightly reduced, and immunoglobulin levels are normal to elevated. However, T cell proliferative response to mitogens and antigens is compromised and specific antibody response to vaccination is impaired.",
"   </p>",
"   <p>",
"    The two deficiencies have similarities and differences in their clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Two siblings reported with ORAI1 deficiency presented at two weeks of age with fever and failure to thrive. The first child died from sepsis at 11 months of age. The younger sibling was successfully transplanted at 16 weeks of age. Three siblings with STIM1 deficiency developed infections within the first two months of life. The eldest survived until nine years of age, dying from hematopoietic cell transplantation complications. The younger sister died at 18 months from encephalitis. The third sibling, a boy, was successfully transplanted at 15 months of age.",
"   </p>",
"   <p>",
"    Nonprogressive muscular hypotonia and abnormalities in dental enamel are seen in both ORAI1 and STIM1 deficiencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Two surviving patients with ORAI1 deficiency have more extensive ectodermal defects (ectodermal dysplasia and anhidrosis). The three siblings with STIM1 deficiency all had autoimmune disorders and the two who were not transplanted had lymphoproliferative disorders. A unique feature of STIM1 deficiency is partial iris hypoplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DEFECTS OF NF-KAPPA-B REGULATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     NEMO and NFKBIA (IKBA) deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomorphic gene defects that result in partial function of the inhibitor of nuclear factor-kappa-B (NF-kappa-B) or the kinase that inactivates the inhibitor cause a combined immunodeficiency with variable associated features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;NF-kappa-B is a transcription factor that regulates expression of a large number of genes with roles in immune and inflammatory responses to pathogens. Examples include genes encoding acute phase proteins, adhesion molecules, and the cytokines interleukin-1, -2, -6, -8, G- and GM-CSF, and TNF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. NF-kappa-B also regulates development of other tissues such as skin, hair, and teeth.",
"   </p>",
"   <p>",
"    The activity of NF-kappa-B is controlled by NF-kappa-B inhibitor proteins alpha and beta (NFKBIA and NFKBIB), also called the inhibitor of kappa B (I-kappa-B alpha and beta, IKBA, and IKBB). These inhibitors inactivate NF-kappa-B by trapping it in the cytoplasm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. NF-kappa-B is active when the inhibitor is degraded after phosphorylation by I kappa B kinase (IKK). IKK is a heterotrimer of alpha, beta, and gamma chains. Mutations in NFKBI or IKK lead to decreased NF-kappa B activity.",
"   </p>",
"   <p>",
"    The IKK gamma chain (IKBKG, also called NF-kappa-B essential modifier or NEMO, MIM 300248) is encoded by a gene on the X chromosome. The NF-kappa-B inhibitor alpha (NFKBIA, also called I-kappa-B alpha or IKBA, MIM 164008) is encoded on chromosome 14q13. Mutations in NFKBIA lead to constitutive activity of the inhibitor and a partial block of NF-kappa-B signaling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypomorphic mutations that allow partial function of NEMO typically cause an X-linked syndrome of antibody deficiency, increased susceptibility to infection with nontuberculous mycobacteria, and ectodermal dysplasia (MIM 300291) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/23-31\">",
"     23-31",
"    </a>",
"    ]. Ectodermal dysplasia is characterized by conical or absent teeth, fine sparse hair, and hypohidrosis due to decreased sweat glands.",
"   </p>",
"   <p>",
"    Individuals with NEMO mutations experience severe bacterial or viral infections early in life and atypical mycobacterial infections. Failure to thrive, recurrent gastrointestinal infections with chronic diarrhea, bronchiectasis secondary to recurrent respiratory tract infections, and recurrent skin infections are common findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/32\">",
"     32",
"    </a>",
"    ]. Other Mendelian susceptibility to mycobacterial diseases (MSMD) disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4297?source=see_link\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with NEMO mutations also have osteopetrosis and lymphedema associated with ectodermal dysplasia and immunodeficiency. Thus, these syndromes are sometimes distinguished as \"ectodermal dysplasia with immunodeficiency\" (EDA-ID) and \"osteopetrosis and lymphedema with ectodermal dysplasia and immunodeficiency\" (OL-EDA-ID) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While all NEMO mutations result in immunodeficiency, they do not all result in ectodermal dysplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/25,26,34\">",
"     25,26,34",
"    </a>",
"    ]. Thus, male patients with atypical mycobacterial infections and immunologic laboratory findings consistent with NEMO mutation should be evaluated for NEMO deficiency.",
"   </p>",
"   <p>",
"    A mutation in the 5&rsquo; untranslated region of NEMO causing decreased expression of normal protein was reported in two brothers with a history of recurrent sinopulmonary infections and dysgammaglobulinemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Null (amorphic) mutations of NEMO lead to the X-linked dominant disorder incontinentia pigmenti, which is lethal in males. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=see_link&amp;anchor=H29839499#H29839499\">",
"     \"The genodermatoses\", section on 'Incontinentia pigmenti'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several patients have been described with an autosomal dominant form of anhidrotic ectodermal dysplasia with T cell immunodeficiency due to mutations in the gene for NF-kappa-B inhibitor alpha (NFKBIA, MIM 612132) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. The phenotype is very similar to NEMO deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/30\">",
"     30",
"    </a>",
"    ]. These patients generally present in infancy with failure to thrive, recurrent respiratory and gastrointestinal tract infections, and chronic diarrhea. These patients are also prone to atypical mycobacterial infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunologic findings in NEMO deficiency include hypogammaglobulinemia with poor specific antibody production (particularly in response to polysaccharide antigens), either elevated IgM or IgA, and low NK cell function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/23-25,32\">",
"     23-25,32",
"    </a>",
"    ]. Some consider NEMO deficiency a form of the hyper immunoglobulin M (IgM) syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/40\">",
"     40",
"    </a>",
"    ]; however, this is misleading since patients with NEMO deficiency more often have elevated serum IgA, rather than IgM. Cellular responses to T cell mitogens and recall antigens in vitro are variable.",
"   </p>",
"   <p>",
"    Persistent lymphocytosis, generally with a normal distribution of T, B, and NK cells, normal T cell responses to mitogens, and impaired production of cytokines regulated by NFKBIA are common laboratory findings in patients with NFKBIA (IKBA) deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. However, immunoglobulin levels and T cell responses to antigens are variable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of Toll-like receptor function may reveal defects due to impaired NF-kappa-B signaling in patients with characteristic clinical and laboratory features. The gene structure should be determined if Toll-like receptor function is abnormal. Establishing the molecular diagnosis is important for definitive therapy and genetic counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune globulin replacement is indicated in patients with NEMO or NFKBIA deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/25,36\">",
"     25,36",
"    </a>",
"    ]. In some patients, significant bacterial infections may still occur, in spite of immune globulin therapy. Treatment of active mycobacterial infections is adjusted according to disease severity and antimicrobial sensitivity. Young patients who have not yet been diagnosed with Mycobacterium avium infection can be treated with antimycobacterial prophylaxis. Surgical treatment of foci of infection may be necessary, particularly for mycobacterial infections. Chronic herpes antiviral prophylaxis is often used in patients who have herpesvirus infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14087?source=see_link\">",
"     \"Immune globulin therapy in primary immunodeficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4297?source=see_link\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Survival ranges from early infancy to late adolescence, with many patients dying in early childhood. The severe course of many patients should lead to consideration of hematopoietic cell transplantation (HCT), especially in patients who have an HLA-identical sibling donor and have not yet experienced mycobacterial infection. HCT will not ameliorate ectodermal dysplasia, if present. One patient with NFKBIA deficiency was treated successfully with HCT, but another died from transplant complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/36,39,41\">",
"     36,39,41",
"    </a>",
"    ]. Patients with NEMO deficiency have also been transplanted successfully, but may not have resolution of all of the clinical manifestations of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;WHIM syndrome (MIM 193670) is usually inherited as an autosomal dominant trait resulting from mutations in the CXC chemokine receptor 4 (CXCR4, MIM 162643) gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. CXCR4 is involved in organogenesis, hematopoiesis, and immune responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/45\">",
"     45",
"    </a>",
"    ]. Mutations in the CXCR4 gene cause an enhanced leukocyte response to the CXCR4 ligand, CXCL12. One consequence of this enhanced signaling is myelokathexis (retention and increased apoptosis of mature neutrophils in the bone marrow with resulting peripheral neutropenia).",
"   </p>",
"   <p>",
"    Mutations in the CXCR4 gene are not present in all patients with WHIM syndrome. In such patients, enhanced leukocyte responsiveness to CXCL12 may be due to defects in components involved in CXCR4 internalization and desensitization, such as the G protein-coupled receptor kinase 3 (GRK3) and arrestin-beta-2 (ARRB2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/43,46,47\">",
"     43,46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As the name of this syndrome suggests, these patients have increased susceptibility to human papillomavirus and chronic verrucosis, low immunoglobulin levels, recurrent respiratory tract infections, and neutropenia due to retention of mature neutrophils in the bone marrow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. However, the phenotype is variable and not all patients have hypogammaglobulinemia or increased susceptibility to human papillomavirus infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/51\">",
"     51",
"    </a>",
"    ]. Clinically, patients present with recurrent sinopulmonary bacterial infections characteristic of antibody deficiencies.",
"   </p>",
"   <p>",
"    In small case series, leukopenia is common, primarily due to neutropenia, although moderate lymphopenia is also seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/51\">",
"     51",
"    </a>",
"    ]. Peripheral blood neutrophil counts are low (&lt;500",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    although function is normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/48,52\">",
"     48,52",
"    </a>",
"    ]. Bone marrow biopsy reveals mature neutrophils. Levels of IgG",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    IgA may be below normal. Antibody responses to vaccines are usually normal, but may decrease rapidly, with absent protective titers one year after vaccination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/51\">",
"     51",
"    </a>",
"    ]. Peripheral blood lymphocytes are generally functionally normal, but in vitro proliferative responses to mitogens and antigens may be impaired, and cutaneous anergy with delayed hypersensitivity skin testing may also be seen.",
"   </p>",
"   <p>",
"    Immune globulin is effective for reducing bacterial infections in patients with WHIM syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/48\">",
"     48",
"    </a>",
"    ]. Therapy with either G-CSF or GM-CSF results in increases in peripheral blood neutrophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/48\">",
"     48",
"    </a>",
"    ]. Treatment with the CXCR4 antagonist and stem cell mobilizing agent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/12/27844?source=see_link\">",
"     plerixafor",
"    </a>",
"    is under investigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14087?source=see_link\">",
"     \"Immune globulin therapy in primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26880425\">",
"    <span class=\"h2\">",
"     Serine threonine kinase 4 (STK4) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serine threonine kinase 4 (STK4, also called mammalian sterile 20-like protein 1, MST1; MIM 604965) is part of a signaling pathway that controls cell growth, apoptosis, and tumorigenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seven patients from three consanguineous families have been described with STK4 deficiency due to homozygous mutations in",
"    <em>",
"     STK4",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The age at presentation of these patients ranged from the first one to two years of life to 10 years of age. Two siblings in one of the families died in the first year of life from septicemia (STK4 deficiency suspected but not documented in these patients). Common clinical features reported were recurrent skin and respiratory tract infections (bacterial and viral), bronchiectasis, mucocutaneous candidiasis, extensive molluscum contagiosum, eczematous skin lesions, Epstein-Barr virus (EBV)-associated lymphoproliferative syndrome and lymphoma, and asymptomatic structural cardiac abnormalities. Growth was normal in all patients.",
"   </p>",
"   <p>",
"    Patients had progressive T cell lymphopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. B and NK cell numbers were low to normal. Hypergammaglobulinemia (IgG, A, and E) was reported in most patients, while IgM was low to normal. Specific antibody levels were low to normal. Intermittent neutropenia was also reported. A higher rate of lymphocyte apoptosis was seen.",
"   </p>",
"   <p>",
"    One patient was successfully treated with HCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/57\">",
"     57",
"    </a>",
"    ]. Her two older siblings died from graft-versus-host disease (GVHD) and infectious complications post HCT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Caspase-8 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caspases are a family of proteases that play roles in signal transduction by inflammatory cytokine receptors (eg, IL-1 and IL-18) as well as in pathways leading to programmed cell death (apoptosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only two patients with caspase-8 deficiency (MIM 697271) due to a mutation in the CASP8 gene have been described to date [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/59\">",
"     59",
"    </a>",
"    ]. These are siblings who presented at 11 and 12 years of age with recurrent sinopulmonary bacterial infections and herpes simplex virus infections, poor growth, lymphadenopathy and splenomegaly, eczema, and asthma. Caspase-8 deficiency is also referred to as autoimmune lymphoproliferative syndrome type IIB (ALPS2B).",
"   </p>",
"   <p>",
"    Immunoglobulin levels were normal in these two patients, although they had poor responses to S. pneumococcus and diminished production of IgG and IgM in vitro. The percentage of CD4+ T cells was low (about 25 percent of lymphocytes) and the",
"    <span class=\"nowrap\">",
"     CD4/CD8",
"    </span>",
"    ratio was 0.5. T cells showed decreased proliferation and IL-2 production in vitro with mitogens, and NK cell function was also impaired.",
"   </p>",
"   <p>",
"    There are no published data regarding therapy for these patients. Management is directed toward infectious complications and may include immune globulin replacement. Caspase-8 is ubiquitously expressed, and therefore one cannot predict that hematopoietic cell transplantation would be curative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     CD8 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;CD8 is a T cell receptor (TCR) accessory molecule that binds to Class I MHC. CD8 is primarily expressed on cytotoxic T cells, but is also found on natural killer (NK) cells. It plays an important role in the antigen-specific activation and function of cytotoxic T cells. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"     \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CD8 deficiency due to a homozygous mutation in the gene for the CD8 alpha chain (CD8A) on chromosome 2p12 (MIM 608957) was reported in three offspring of consanguineous parents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/60\">",
"     60",
"    </a>",
"    ]. Only one of them, a 25 year old male, was symptomatic. He had recurrent sinopulmonary infections beginning around age five years, which suggested a humoral deficiency. However, his immunoglobulin levels and specific antibody titers were normal. CD4+ T cell, B cell, and NK cell percentages and absolute counts were normal, but CD8+ T cells were completely absent. He had two younger sisters who also had absent CD8+ T cells, but were asymptomatic at the time of the report. Genetic defects were not described in these patients. This phenotype could be consistent with defects of the ZAP-70 kinase, defects of MHC class I expression, or defects of CD8 itself. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/2/42022?source=see_link\">",
"     \"ZAP-70 deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=see_link\">",
"     \"CD3/T cell receptor complex disorders causing immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no published data regarding therapy for these patients. Management is directed toward infectious complications and may include immune globulin replacement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30106040\">",
"    <span class=\"h2\">",
"     CD27 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;CD27 is a member of the tumor necrosis factor receptor superfamily (TNFRSF7) and its ligand, CD70 (TNFSF7), is expressed on activated T and B cells. CD27 plays a role in T, B, and NK cell differentiation, function, and survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31098?source=see_link\">",
"     \"Normal B and T lymphocyte development\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two brothers of consanguineous parents were identified with a homozygous mutation in",
"    <em>",
"     CD27",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/61\">",
"     61",
"    </a>",
"    ]. Both brothers had persistent symptomatic Epstein-Barr virus (EBV) viremia. The index patient, who was diagnosed at 21 years of age, also had hypogammaglobulinemia and was initially thought to have common variable immunodeficiency (CVID). The brother died of fulminant gram-positive bacteria sepsis and aplastic anemia. An older sister died in infancy of an unknown cause. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=see_link\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/45/38617?source=see_link\">",
"     \"Common variable immunodeficiency in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The index patient had no CD27+ T or memory B cells. Plasmablast formation via T cell-dependent stimulation was absent and antibody production was impaired. A reduced T cell response was seen to mitogens that strongly depend upon CD27, but response to recall antigens was normal. NK cell numbers, differentiation, and cytotoxic function were all normal.",
"   </p>",
"   <p>",
"    There are no published data regarding therapy for these patients. Management is directed toward infectious complications and may include immune globulin replacement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Dedicator of cytokinesis 8 (DOCK8) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several patients have been identified with loss-of-function homozygous or compound heterozygous mutations in an uncharacterized gene,",
"    <em>",
"     DOCK8",
"    </em>",
"    , that is expressed in lymphocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. Some of these patients were previously thought to have autosomal recessive hyperimmunoglobulin E syndrome (HIES). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/25/32153?source=see_link\">",
"     \"Hyperimmunoglobulin E syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients have low absolute lymphocyte counts, including low T cells; B and NK cells are also low in many patients. CD8 T cell survival and function are impaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/65\">",
"     65",
"    </a>",
"    ]. Most patients also have eosinophilia and elevated IgE. IgM levels are low, but many patients have increased IgG levels. IgG antibody responses to bacterial and viral antigens are variable.",
"   </p>",
"   <p>",
"    Common clinical features include recurrent respiratory tract infections (otitis media, sinusitis, pneumonia), extensive cutaneous viral infections (herpes simplex virus, herpes zoster, molluscum contagiosum, human papillomavirus), Staphylococcus aureus skin infections, atopic disease (atopic dermatitis, severe food and environmental allergies, asthma), and cancer (vulvar, facial, and anal squamous cell dysplasia and carcinomas, and T cell lymphoma-leukemia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/50,62-64,66\">",
"     50,62-64,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Newborn rash and coarse facies are clinical manifestations seen in HIES that are absent in DOCK8 deficiency. In addition, higher rates of malignancy and mortality are seen in DOCK8 deficiency compared with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A few patients with DOCK8 deficiency have successfully undergone treatment with hematopoietic cell transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/67-69\">",
"     67-69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4018211\">",
"    <span class=\"h2\">",
"     Hypomorphic RAG1 and RAG2 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in recombination activating genes 1 and 2 (RAG1 and RAG2) can cause SCID. However, &ldquo;leaky&rdquo; hypomorphic mutations with partial protein function can have a variable presentation, including granulomatous skin disease, disseminated infection with nontuberculous mycobacteria, autoimmune disease, and isolated T cell lymphopenia with later onset of infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/58/40873/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20362?source=see_link\">",
"     \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Several genetic mutations lead to variable defects of humoral and cell-mediated immunity (",
"      <a class=\"graphic graphic_table graphicRef64286 \" href=\"mobipreview.htm?14/41/15006\">",
"       table 1",
"      </a>",
"      ). Combined immunodeficiency syndromes are somewhat arbitrarily distinguished from severe combined immunodeficiency (SCID) in that they do not characteristically lead to death from overwhelming infection in the first year of life. In some cases, mutations of a particular gene may lead to SCID or to milder combined immunodeficiency, depending upon the extent of the gene defect. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with combined immunodeficiency often present in the first two years of life with recurrent infections and specific findings associated with the different syndromes. However, patients with milder defects may not present until later in childhood or even early adulthood. Many of the combined immunodeficiency syndromes have characteristic-associated clinical features that suggest a particular defect and help direct the diagnostic evaluation. The choice of treatment depends upon the type and severity of the immune defect. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Defects of NF-kappa-B regulation, including mutations in NEMO (IKBKG) and NFKBIA (IKBA), cause a combined immunodeficiency usually associated with ectodermal dysplasia. Patients experience severe bacterial or viral infections early in life. Those with NEMO defects also have increased susceptibility to infection with nontuberculous mycobacteria. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Defects of NF-kappa-B regulation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/1\">",
"      International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009; 124:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/2\">",
"      Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 1997; 94:3168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/3\">",
"      Roifman CM. Human IL-2 receptor alpha chain deficiency. Pediatr Res 2000; 48:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/4\">",
"      Caudy AA, Reddy ST, Chatila T, et al. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007; 119:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/5\">",
"      Aoki CA, Roifman CM, Lian ZX, et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006; 27:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/6\">",
"      Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/7\">",
"      Cohen AC, Nadeau KC, Tu W, et al. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol 2006; 177:2770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/8\">",
"      Bernasconi A, Marino R, Ribas A, et al. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 2006; 118:e1584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/9\">",
"      Hwa V, Camacho-H&uuml;bner C, Little BM, et al. Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene. Horm Res 2007; 68:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/10\">",
"      Hwa V, Little B, Adiyaman P, et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 2005; 90:4260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/11\">",
"      Vidarsdottir S, Walenkamp MJ, Pereira AM, et al. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab 2006; 91:3482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/12\">",
"      Nadeau K, Hwa V, Rosenfeld RG. STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 2011; 158:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/13\">",
"      Pignata C, Fiore M, Guzzetta V, et al. Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet 1996; 65:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/14\">",
"      Frank J, Pignata C, Panteleyev AA, et al. Exposing the human nude phenotype. Nature 1999; 398:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/15\">",
"      Amorosi S, D'Armiento M, Calcagno G, et al. FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus. Clin Genet 2008; 73:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/16\">",
"      Adriani M, Martinez-Mir A, Fusco F, et al. Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population. Ann Hum Genet 2004; 68:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/17\">",
"      Gwack Y, Feske S, Srikanth S, et al. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 2007; 42:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/18\">",
"      Mignen O, Thompson JL, Shuttleworth TJ. Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J Physiol 2008; 586:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/19\">",
"      Feske S, Gwack Y, Prakriya M, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/20\">",
"      Picard C, McCarl CA, Papolos A, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009; 360:1971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/21\">",
"      McCarl CA, Picard C, Khalil S, et al. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 2009; 124:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/22\">",
"      Feske S, Picard C, Fischer A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol 2010; 135:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/23\">",
"      Orange JS, Geha RS. Finding NEMO: genetic disorders of NF-[kappa]B activation. J Clin Invest 2003; 112:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/24\">",
"      Puel A, Picard C, Ku CL, et al. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 2004; 16:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/25\">",
"      Orange JS, Jain A, Ballas ZK, et al. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 2004; 113:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/26\">",
"      Orange JS, Levy O, Brodeur SR, et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol 2004; 114:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/27\">",
"      Hanson EP, Monaco-Shawver L, Solt LA, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 2008; 122:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/28\">",
"      Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008; 122:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/29\">",
"      Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000; 67:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/30\">",
"      Ku CL, Yang K, Bustamante J, et al. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol Rev 2005; 203:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/31\">",
"      Faletra F, Bruno I, Berti I, et al. A red baby should not be taken too lightly. Acta Paediatr 2012; 101:e573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/32\">",
"      D&ouml;ffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/33\">",
"      Roberts CM, Angus JE, Leach IH, et al. A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID). Eur J Pediatr 2010; 169:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/34\">",
"      Niehues T, Reichenbach J, Neubert J, et al. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 2004; 114:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/35\">",
"      Mooster JL, Cancrini C, Simonetti A, et al. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene. J Allergy Clin Immunol 2010; 126:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/36\">",
"      Courtois G, Smahi A, Reichenbach J, et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003; 112:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/37\">",
"      Janssen R, van Wengen A, Hoeve MA, et al. The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. J Exp Med 2004; 200:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/38\">",
"      McDonald DR, Mooster JL, Reddy M, et al. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol 2007; 120:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/39\">",
"      Lopez-Granados E, Keenan JE, Kinney MC, et al. A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat 2008; 29:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/40\">",
"      Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005; 105:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/41\">",
"      Dupuis-Girod S, Cancrini C, Le Deist F, et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006; 118:e205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/42\">",
"      Pai SY, Levy O, Jabara HH, et al. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. J Allergy Clin Immunol 2008; 122:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/43\">",
"      Kawai T, Malech HL. WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol 2009; 16:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/44\">",
"      Liu Q, Chen H, Ojode T, et al. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood 2012; 120:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/45\">",
"      Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007; 1768:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/46\">",
"      Lagane B, Chow KY, Balabanian K, et al. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 2008; 112:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/47\">",
"      Balabanian K, Levoye A, Klemm L, et al. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest 2008; 118:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/48\">",
"      Wetzler M, Talpaz M, Kleinerman ES, et al. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med 1990; 89:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/49\">",
"      Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003; 34:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/50\">",
"      Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol 2012; 130:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/51\">",
"      Tassone L, Notarangelo LD, Bonomi V, et al. Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients. J Allergy Clin Immunol 2009; 123:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/52\">",
"      Hord JD, Whitlock JA, Gay JC, Lukens JN. Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. J Pediatr Hematol Oncol 1997; 19:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/53\">",
"      McDermott DH, Liu Q, Ulrick J, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 2011; 118:4957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/54\">",
"      Dale DC, Bolyard AA, Kelley ML, et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 2011; 118:4963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/55\">",
"      Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/56\">",
"      Abdollahpour H, Appaswamy G, Kotlarz D, et al. The phenotype of human STK4 deficiency. Blood 2012; 119:3450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/57\">",
"      Nehme NT, Pachlopnik Schmid J, Debeurme F, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 2012; 119:3458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/58\">",
"      Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003; 193:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/59\">",
"      Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/60\">",
"      de la Calle-Martin O, Hernandez M, Ordi J, et al. Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 2001; 108:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/61\">",
"      van Montfrans JM, Hoepelman AI, Otto S, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012; 129:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/62\">",
"      Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009; 361:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/63\">",
"      Engelhardt KR, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/64\">",
"      Su HC. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol 2010; 10:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/65\">",
"      Randall KL, Chan SS, Ma CS, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med 2011; 208:2305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/66\">",
"      Chu EY, Freeman AF, Jing H, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 2012; 148:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/67\">",
"      Bittner TC, Pannicke U, Renner ED, et al. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr 2010; 222:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/68\">",
"      Barlogis V, Galambrun C, Chambost H, et al. Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol 2011; 128:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/69\">",
"      Boztug H, Karitnig-Wei&szlig; C, Ausserer B, et al. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol 2012; 29:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/70\">",
"      Avila EM, Uzel G, Hsu A, et al. Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics 2010; 126:e1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/58/40873/abstract/71\">",
"      Schuetz C, Huck K, Gudowius S, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med 2008; 358:2030.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3935 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-1759BFA714-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40873=[""].join("\n");
var outline_f39_58_40873=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SCID VARIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Interleukin-2 receptor alpha chain (CD25) deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Signal transducer and activator of transcription 5b (STAT5b) deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Winged-helix nude (FOXN1) deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ORAI1/CRACM1 and STIM1 deficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DEFECTS OF NF-KAPPA-B REGULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      NEMO and NFKBIA (IKBA) deficiencies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26880425\">",
"      Serine threonine kinase 4 (STK4) deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Caspase-8 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      CD8 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30106040\">",
"      CD27 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Dedicator of cytokinesis 8 (DOCK8) deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4018211\">",
"      Hypomorphic RAG1 and RAG2 mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3935\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3935|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/41/15006\" title=\"table 1\">",
"      Syndromes combined immunodef",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/27/2488?source=related_link\">",
"      Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=related_link\">",
"      Ataxia-telangiectasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28329?source=related_link\">",
"      CD3/T cell receptor complex disorders causing immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7992?source=related_link\">",
"      Cartilage-hair hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22553?source=related_link\">",
"      Chronic mucocutaneous candidiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/45/38617?source=related_link\">",
"      Common variable immunodeficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/2/1066?source=related_link\">",
"      Hematopoietic cell transplantation for primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/25/32153?source=related_link\">",
"      Hyperimmunoglobulin E syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/32/21001?source=related_link\">",
"      Hyperimmunoglobulin M syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/15/25850?source=related_link\">",
"      IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14087?source=related_link\">",
"      Immune globulin therapy in primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/12/4297?source=related_link\">",
"      Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/27/439?source=related_link\">",
"      Nijmegen breakage syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31098?source=related_link\">",
"      Normal B and T lymphocyte development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/52/2889?source=related_link\">",
"      Prophylaxis against Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/22/40295?source=related_link\">",
"      Syndromic immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20362?source=related_link\">",
"      T cell negative, B cell negative, NK cell positive severe combined immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33384?source=related_link\">",
"      X-linked lymphoproliferative disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/2/42022?source=related_link\">",
"      ZAP-70 deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_58_40874="Acute anteroseptal MI tutorial";
var content_f39_58_40874=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1255px;\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Acute anteroseptal myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 148px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ST segment elevation in V1 and V2 is characteristic of an acute anteroseptal infarct. There is also reciprocal ST segment depression in V5 and V6.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40874=[""].join("\n");
var outline_f39_58_40874=null;
var title_f39_58_40875="Challenges neural blockade";
var content_f39_58_40875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anatomic, physiological, and pharmacological challenges in neural blockade for cancer pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physiologic and pharmacologic issues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Local anesthetic at any given concentration can affect a variable distribution of nerve fibers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sodium channel closure by the local anesthetic is dependent upon the activity of the nerve; local anesthetics produce more effect on active nerves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic redistribution of local anesthetic following nerve blocks may result in effects that are comparable to systemic administration. Systemic doses of local anesthetic can inhibit impulses from injured nerves.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All procedures can produce a \"placebo\" response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Anatomic considerations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anatomic variability, particularly unreliable surface anatomical landmarks, make precise nerve localization for injection difficult",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neural soft tissue is not well demonstrated on radiographic imaging techniques like CT scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autonomic, sensory and somatic components of the pain are not always separable by peripheral or central neural blockade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The sympathetic nerves carry both efferent and afferent neural information",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Many body regions have more than one innervation; several nerves to an affected area may require injection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The local anesthetic can spread to adjacent tissues; the target tissue may not be the source of the pain, but may appear so as a result of local anesthetic spreading to the actual generator of the pain",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40875=[""].join("\n");
var outline_f39_58_40875=null;
var title_f39_58_40876="Signs symptoms allergic reaction during OFC";
var content_f39_58_40876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Signs and symptoms of an allergic reaction to monitor for during an oral food challenge",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Skin:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Feeling of warmth, flushing [erythema], itching [may begin on palms and soles], urticaria, angioedema, morbilliform rash, and \"hair standing on end\" [piloerection]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infants and children: eczematous flare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Oral:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Itching or tingling of lips, tongue, or palate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Edema of lips, tongue, uvula, metallic taste",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infants: drooling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Children: rubbing tongue against pruritic palate, scratching tongue with hand",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Gastrointestinal:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nausea, abdominal pain [colic, cramps], vomiting [large amounts of \"stringy\" mucus], and diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Difficulty swallowing*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Respiratory:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Laryngeal - pruritus and \"tightness\" in the throat, dysphagia, dysphonia and hoarseness, and sensation of itching in the external auditory canals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lung - shortness of breath, dyspnea, chest tightness, deep or repetitive cough, and wheezing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nose - itching, congestion, rhinorrhea, and sneezing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiovascular:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Feeling of faintness or dizziness; syncope, chest pain, palpitations, and/or hypotension (tunnel vision, difficulty hearing)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Neurologic:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anxiety, apprehension, sense of impending doom, seizures, confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infants: lethargy, hypotonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Children: abrupt cessation of activity, fetal position",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Ocular:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Periorbital itching, erythema and edema, tearing, and conjunctival erythema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lower back pain due to uterine cramping in women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Children: ear pulling as an indication of pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Vital signs/other objective measures:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulse oximetry, respiratory rate, peak flow, pulmonary function testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulse, blood pressure",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Often occurs in association with throat tightness and other upper airway symptoms.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40876=[""].join("\n");
var outline_f39_58_40876=null;
var title_f39_58_40877="Causes of PALF in North America and Europe";
var content_f39_58_40877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83285&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83285&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of acute liver failure in children in North America and Europe (final diagnosis as percent of cases in each age group)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"7\" width=\"14%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Final diagnosis",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"6\">",
"        Percent of cases in each age group",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &lt;4 weeks",
"       </td>",
"       <td class=\"subtitle2\">",
"        4 to 8 weeks",
"       </td>",
"       <td class=\"subtitle2\">",
"        9 weeks to 1 year",
"       </td>",
"       <td class=\"subtitle2\">",
"        1 to 5 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        6 to 10 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        &gt;10 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indeterminate",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         38",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         41",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         45",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         67",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         62",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         32",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acetaminophen (paracetamol)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         29",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         16",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         27",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         20",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        8",
"       </td>",
"       <td class=\"centered\">",
"        9*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         10",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viral hepatitis",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         22",
"        </span>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shock/ischemia",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug-induced",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gestational alloimmune liver disease (neonatal hemochromatosis)",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         14",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         14",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Veno-occlusive disease",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemophagocytic syndrome",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Budd-Chiari syndrome",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other diagnosis",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple diagnoses",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Data from the Pediatric Acute Liver Failure Study Group, 2000-2007. The most common causes of liver failure in each age group are shown in",
"    <span style=\"color: #ff0000;\">",
"     red",
"    </span>",
"    font.",
"    <div class=\"footnotes\">",
"     * In children 10 years or older, Wilson disease accounted for 90 percent of children with metabolic acute liver failure.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Squires RH, Alonso EM. Acute liver failure in children. In: Liver Disease in Children, 4th ed, Suchy FJ, Sokol RJ, Balistreri WF (Eds), Cambridge University Press, New York 2012. Copyright &copy; 2012 Cambridge University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40877=[""].join("\n");
var outline_f39_58_40877=null;
var title_f39_58_40878="Reabsorption secretion nephron";
var content_f39_58_40878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F64169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F64169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schematic representation of reabsorption and secretion in the nephron",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 273px; height: 202px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40878=[""].join("\n");
var outline_f39_58_40878=null;
var title_f39_58_40879="Hernia mimicking ptx";
var content_f39_58_40879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of a hernia mimicking a pneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph demonstrates a herniated, gas-filled stomach through a rent in the left hemidiaphragm, mimicking a left-sided tension pneumothorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_58_40879=[""].join("\n");
var outline_f39_58_40879=null;
